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The cerebral cortex forms the major part of the dorsal telencephalon and contains a 
highly diverse population of neurons that form complex neuronal networks, which is 
key in higher cognitive functions. Despite its complexity, recent findings have shown 
that this highly organised cytoarchitecture can be recapitulated spatio-temporally in a 
3D in vitro model known as cerebral organoids. This provides a new platform to 
investigate corticogenesis in a more accessible and controlled environment. However, 
as mechanisms underlying the development of cerebral organoids are much less 
understood, the accuracy of this model as a tool in investigating cortical development 
remains an unanswered question. 
 
To address this question, this study investigates the cerebral organoid system by 
removing Pax6, one of the crucial transcription factors involved in early 
corticogenesis. This study aims to compare phenotypes of Pax6-/- mouse cerebral 
organoids to the established phenotypes of Pax6-/- mouse embryonic cortices, which 
will provide insights to whether the roles of Pax6 in cerebral organoids accurately 
match with its function in vivo. Using an established 3D culture protocol that 
generates robust neuroepithelial-like (NE) structures, we found that Pax6-/- cerebral 
organoids show precocious differentiation, with similar characteristics to Pax6-/- 
embryonic cortices, such as an increase of abventricular mitotic cells and alteration in 
the labelling index of cells in S-phase. These results suggest a consistent role for Pax6 
in cortical development in both 3D in vitro and in vivo models. 
 
Recent studies have shown that Pax6 controls proliferation of cortical progenitors by 




cerebral organoids, Pax6 conditional knockout (cKO) embryonic stem (ES) cell lines 
were derived from tamoxifen-inducible Pax6 cKO mice. This enabled the generation 
of cerebral organoids that can be interrogated by acute deletion of Pax6 in the cortex-
specific region.  
 
Using a combination of cumulative EdU labelling and mosaic analysis, we found that 
acute deletion of Pax6 in cerebral organoids does not cause significant changes in the 
total cell cycle time (Tc) of the cortical progenitors, consistent with the phenotypes of 
cortical progenitors in the caudo-medial region of Pax6 cKO mice.  This may also 
suggests that Pax6 is cell non-autonomously required in cortical proliferation of 
organoids. In addition, we found that the proliferation rate of cortical progenitors in 
control organoids is slower than embryonic cortical progenitors. 
 
Overall, this study indicates that cell proliferation in cerebral organoids requires Pax6. 
However, the roles of Pax6 in cell cycle regulation in this system remain unclear, due 












Understanding brain development is a major scientific challenge due to the highly 
complex nature of the tissue, which consists of a diverse population of neurons that 
form intricate neuronal networks. The cerebral cortex forms the outermost layer of the 
brain and is responsible for many higher cognitive functions, including thought and 
language processing.  
 
Recent research has shown that the composition and organisation of cortical tissue 
can be closely reproduced in a dish using three-dimensional cell culture techniques to 
generate tissues which bear a remarkable resemblance to a developing brain. These 
structures are known as cerebral organoids, and they provide a more accessible and 
controlled platform in which to study brain development in the lab. However, how 
accurately these structures represent certain aspects of brain development is not 
currently known. 
 
To explore this, this study focuses on the role of a gene called Pax6. Pax6 has been 
identified to be crucial in early cortical development, primarily based on studies 
where the gene has been deleted in mice (Pax6-/-). The aim of this work was to 
compare characteristics of cerebral organoids to the established characteristics of 
Pax6-/- mouse embryonic cortices, which will provide insights to whether the roles of 
Pax6 in cerebral organoids accurately match with its actual role in mouse embryonic 
forebrain. Using the cerebral organoid system, we found that Pax6-/- organoids 
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CHAPTER 1: INTRODUCTION 
	
1.1 Forebrain development  
 
The forebrain confers many of the unique and higher cognitive functions of humans, 
which are rooted in its complex neuronal network.  Dysregulation during 
developmental processes could cause intellectual disabilities and neurodevelopmental 
disorders (Reiner et al., 2016; Tan and Shi, 2013). The principles of forebrain 
development are highly conserved, and therefore many studies have used animal 
models, such as mice to unravel the mechanisms by which development of this 
complex organ proceeds. Therefore, this chapter focuses on mouse embryonic 
forebrain development.  
 
Following neural induction, the neural plate folds and forms a neural tube, an apico-
basally polarised epithelium, which is organised around a lumen, the primordial 
ventricle (Lancaster and Knoblich, 2014). Subsequently, morphogen gradients such as 
Wnt and Sonic hedgehog (Shh) shape the rostro-caudal and dorso-ventral axes of the 














Figure 1.1 Regionalisation of the embryonic forebrain. Morphogen 
gradients such as Wnt and Shh regionalise the rostro-caudal and dorso-







The forebrain emerges from the most rostral part of the neural plate and further 
subdivides into telencephalon and diencephalon, which can be distinguished by the 
expression of molecular marker Foxg1 that marks the prospective telencephalon, but 
is absent in diencephalon (Danesin and Houart, 2012; Wilson and Houart, 2004).  
 
Both of these forebrain subdivisions have reciprocal connections, as the diencephalon 
(thalamus) receives sensory information, which is relayed to the telencephalon 
(cerebral cortex) to be processed, and the feedback is subsequently transmitted back 
to the thalamus, forming a thalamo-cortico-thalamic loop (Antón-Bolaños et al., 
2018). These interactions are fundamental to forebrain function, which is partly 
regulated by the complex neuronal networks in the cerebral cortex. These neuronal 
networks are built upon the interaction of two major types of cortical neurons: 
glutamatergic excitatory neurons and GABAergic inhibitory neurons, with the former 
type comprising the major part of the circuits.  
 
The balance between these two classes of neurons is fundamental for cortical 
function, as disturbance could lead to cognitive dysfunction, causing various 
neurodevelopmental disorders such as autism (Choi et al., 2016; Geschwind and 
Levitt, 2007). Interestingly, these two major types of neurons are born in different 
parts of the telencephalon, as the dorsal telencephalic region generates glutamatergic 
excitatory neurons that migrate radially to the cortical plate and the ventral 
telencephalic region generates GABAergic inhibitory neurons that migrate 






1.1.1 Building blocks of cortical development  
 
The cerebral cortex is the major and most complex part of dorsal telencephalon, 
consisting of a heterogeneous population of neurons that are spatio-temporally 
organised into six cortical layers according to their birth-date (Gaspard and 
Vanderhaeghen, 2011). This complex cytoarchitecture started as a simple 
pseudostratified neuroepithelium (NE) with apico-basal polarity, radially organised 
around lumen, the primordial ventricle (Suzuki and Vanderhaeghen, 2015).  
 
Cortical progenitors are the basic unit of the developing cortex, which is also the basis 
of neuronal diversity. There are two major types of cortical progenitors, namely apical 
and basal progenitors, which can be distinguished based on their cellular 
characteristics and expression of specific molecular markers (Figure 1.2, Manuel et 



















Figure 1.2 The complex and organised cytoarchitecture of the cerebral 
cortex. (A) Cortical progenitors such as apical and basal progenitors 
organised into VZ and SVZ, respectively.  (B) These cortical progenitors give 
rise to diverse cortical neurons by undergoing symmetrical and asymmetrical 







For example, apical progenitors such as NE and radial glia (RG) cells are cells that 
reside and divide at the apical side of the cortex (next to the ventricles), forming the 
ventricular zone (VZ). These cells are also characterised by the expression of neural 
progenitor markers, such as Sox2 and Pax6 (Azzarelli et al., 2015). Prior to 
neurogenesis, NE cells divide symmetrically to generate a progenitor pool, and as 
mouse neurogenesis commences around E10.5, these cells transform into RG cells; 
identified with an apical, as well as a basal process that spans the width of the cortex, 
which acts as a scaffold for migrating neurons. Apart from symmetric cell division to 
maintain the progenitor pool, RG cells can also divide asymmetrically to generate 
basal progenitors (Noctor et al., 2004). 
  
Basal progenitors are intermediate progenitors (IPCs) that reside at the basal side of 
the cortex, forming the subventricular zone (SVZ). They are characterised by the lack 
of an apical process, expression of the transcription factor Tbr2, and mainly divide 
symmetrically, giving rise to neurons (Taverna et al., 2014). Cortical neurons are 
arranged in six layers in an inside-out fashion, with early-born neurons form the deep 
layers (VI-V) and the late-born neurons form the upper layers (III and II) of the 
cortex. Layer I is formed the earliest (E10), populated by Cajal-Retzius cells, which 
have migrated from outer regions of the pallium. 
 
How these progenitors could give rise to an intricate but organised structure with 
diverse cortical neurons lies partly in their genetic control, as demonstrated from 
studies using genetically modified mice. These studies show the molecular basis of 





1.1.2 Pax6: a key transcription factor in cortical development  
 
Pax6 is a highly evolutionarily conserved transcription factor, which belongs to the 
Paired-box (Pax) gene family, and it encodes for two DNA-binding domains, the 
paired domain and a homeodomain (Osumi et al., 2008). During development, Pax6 
is expressed in a highly dynamic pattern, including in the forebrain, eye, spinal cord, 
olfactory system and pancreas (Ypsilanti and Rubenstein, 2016). Mutation of Pax6 is 
implicated in aniridia, a congenital human condition characterised by absence of the 
iris, a condition which is homologous to the small eye (Sey) mouse; a mutant mice 
model with a point mutation in the Pax6 gene that results in Pax6 loss of function – 
also known as Pax6-/- mice (Georgala et al., 2011; Hill et al., 1991). Apart from the 
absence of iris and nasal structures, Pax6-/- mice die at birth with a plethora of 
telencephalic defects, such as proliferation, neurogenesis, patterning and neuronal 
migration defects (Georgala et al., 2011; Quinn et al., 2007; Estivill-Torrus et al., 
2002; Stoykova et al., 2000; Simpson et al., 2009).  
  
During telencephalic development in the mouse, expression of Pax6 starts from E8.0 
in a spatio-temporally controlled manner (Osumi et al., 2008). It is specifically 
expressed in the dorsal part of telencephalon, forming a pallial-subpallial boundary, 
separating the dorsal (pallium) and ventral (subpallium) telencephalic regions (Zaki et 
al., 2003). During early corticogenesis, Pax6 is expressed in a gradient pattern, with 
high levels rostro-laterally and low levels caudo-medially, and it becomes more 










Figure 1.3 Expression pattern of Pax6 in the telencephalon. (A) Pax6 is 
expressed in the dorsal part of telencephalon, forming a sharp pallial-
subpallial (PSPB) boundary between the dorsal and ventral telencephalon. (B, 
C) Expression of Pax6 follows a gradient pattern, with high rostro-laterally and 











Recent studies demonstrate that the roles of Pax6 in cortical development may be 
partly due to Pax6 control in the proliferation of cortical progenitors (Mi et al., 2018; 
Georgala et al., 2011; Manuel et al., 2006; Estivill-Torrus et al., 2002). 
 
1.1.3 Pax6 regulates proliferation of cortical progenitors 
	
	
During cortical development, expression of Pax6 is restricted to the apical cortical 
progenitors, such as NE and RG cells in the VZ (Manuel et al., 2015). As 
neurogenesis commences, RG cells divide asymmetrically, giving rise to either an 
apical progenitor, which maintains Pax6 expression, or to a basal progenitor, as Pax6 
is downregulated and Tbr2 is upregulated (Englund et al., 2005). This indicates the 
requirement of Pax6 in maintaining the balance of cortical progenitor proliferation, 
which is fundamental for proper cortical development. 
 
The role of Pax6 in cortical progenitor proliferation is well-established, and was 
mainly discovered using Pax6 loss-of-function mice (Pax6-/-) and cortex-specific 
Pax6 conditional knock-out mice (cKO). The former is a classic Pax6 mutant mouse 
model with constitutive loss of Pax6; therefore Pax6 is lost in all types of tissues at all 
times, resulting in cumulative defects that might not be specific to Pax6. Embryos 
from this model die at birth, and the roles of Pax6 can therefore only be studied 
during the embryonic stage. The latter is a Pax6 conditional mutant mouse model, 
which enables acute Pax6 deletion in a specific region. This control allows the 
determination of the direct effects of Pax6 at a specific time and region (in this case, 
the cortex); therefore embryos of this model survive beyond birth and the post-natal 




During early cortical development, constitutive loss of Pax6 results in an increase in 
the BrdU labelling index (LI) of the cortical progenitors, suggesting that either the 
cells are proliferating more rapidly or that the length of S-phase increased as a 
proportion of the overall cell cycle length (Warren et al., 1999). Estivill-Torrus et al., 
later quantified the cell cycle kinetics of these Pax6-/- cortical progenitors at different 
stages of corticogenesis and found that constitutive loss of Pax6 at E10.5 and E12.5 
caused a decrease in the total cell cycle time (Tc), which suggests rapid cell 
proliferation. This leads to precocious differentiation, demonstrated by the increase of 
post-mitotic cells expressing Tuj1 (Estivill-Torrus et al., 2002). However increased Tc 
at E15.5 suggests that constitutive loss of Pax6 at later stage of corticogenesis results 
in slower cell proliferation. The distinct effects of the loss of Pax6 at different 
developmental stages suggest the role of Pax6’s in cortical progenitor proliferation is 
context-dependent. 
 
Interestingly, using the same mouse model, another study found no significant change 
in the Tc of E12.5 Pax6-/- cortical progenitors – which is in contrast to the previous 
findings (Quinn et al., 2007). This could be due to the different technique used to 
calculate the Tc; Estivill-Torrus et al used cumulative BrdU labelling, whereas Quinn 
et al used BrdU-IddU double-labelling to label cells undergoing S-phase. In the 
former technique, the Tc is extrapolated from the plotted graph following the protocol 
described by Nowakowski et al., 1998, and the latter technique calculates the Tc 






Nevertheless, a more recent study has reassessed the Tc of E12.5 Pax6-/- mice, taking 
into account the expression gradient of Pax6, which is high rostro-laterally and low 
caudo-medially (Mi et al., 2013). This study revealed that loss of Pax6 only affected 
cortical progenitors in rostro-lateral region, with their Tc significantly decreased, 
compared to control. Similar findings also have been reported in Pax6 cKO mice, 
suggesting that Pax6 repressive control in cortical progenitor proliferation is regulated 
spatio-temporally. Further evidence shows that this is partly due to Pax6 control on 
cell cycle genes, as acute deletion of Pax6 causes upregulation of cell cycle genes, 
particularly Cdk6, which causes a shortening in G1 phase, causing a rapid cell 
proliferation (Mi et al., 2013; Mi et al., 2018). 
 
Although animal models are useful in providing a comprehensive understanding of 
the roles of Pax6 in forebrain development, many cellular processes as well as tissue 
morphogenesis occur simultaneously in utero, which complicates the examination of 
these dynamic interactions (Heemskerk and Warmflash, 2016). For example, due to 
the coordination of extrinsic and intrinsic factors in forebrain development, it is 
difficult to perturb this dynamic system separately without affecting other processes. 
Therefore, an alternative system with a more accessible and controlled environment is 








1.2 Cerebral Organoids: A three-dimensional embryonic stem 
cell model for cortical development  
 
ES cells are pluripotent cells, which are able to give rise to any cell types of the three 
primary germ layers, including into neuroectodermal cells. Classic neural 
differentiation can be performed either via direct differentiation in adherent 
monolayer culture (2D), or via the traditional 3D culture system, which is through the 
formation of embryoid bodies (Tropepe et al., 2001). Embryoid bodies (EBs) are 
multicellular aggregates consisting of cells representative of all the primary germ 
layers (Valamehr et al., 2008). Therefore, EBs are very heterogeneous, and lack 
distinct spatial structures (Simunovic and Brivanlou, 2017). The formation of EBs is 
required as an intermediate stage of the classic lineage-specific differentiation 
protocols (Bain et al., 1995; Bibel et al., 2004). However, subsequent study has shown 
that the formation of EBs is dispensable, as efficient neural induction can be achieved 
through the culture of ES cells in minimal, serum-free medium (Ying et al., 2003). 
Therefore, in the absence of external signalling molecules, ES cells adopt neural fate 
– supporting the default model of neural induction (Muñoz-Sanjuán and Brivanlou, 
2002)  
 
Recent progress using 2D neural differentiation techniques have demonstrated the 
formation of neural rosettes, a group of neural precursor cells in rosette conformation 
(Gaspard et al., 2008). Although the neural rosettes recapitulate spatio-temporal 
patterns characteristic of the cerebral cortex, they lack cell-cell or cell-basement 




to the endogenous biological system and therefore might compromise the accuracy of 
the 2D model (Hwang et al., 2008; Van den Ameele et al., 2014).  
 
The advent of 3D culture systems has paved the path towards the establishment of 
cerebral organoids. Cerebral organoids are neural-like tissues grown from pluripotent 
stem cells in a 3D in vitro culture, with remarkable resemblance to embryonic cortex 
(Lancaster et al., 2013; Qian et al., 2016; Renner et al., 2017). They generate more 
heterogeneous and mature neuronal populations with more complex organisation, 
therefore more closely resembles the cerebral cortex (Eiraku et al., 2008; Nasu et al., 
2012). Their ability to recapitulate cellular complexity and organisation of early 
corticogenesis in vitro offers unprecedented accessibility to unravel the dynamics and 
molecular mechanisms underlying forebrain development. This exciting feature 
means more sophisticated techniques could be applied in cerebral organoids to track 
its development in real-time, as well as multiple genetic modifications using 
CRISPR/Cas9 to understand complex genetic interactions in cortical development, 
which can be done relatively easy in vitro. 
 
Given their ability to recapitulate early cortical development with great cyto-
architectural detail, cerebral organoids have emerged as a new, highly promising tool 
to model the cerebral cortex in vitro. As this 3D model can be established from 
human and mouse ES cells with species-specific characteristics (Eiraku et al., 2008; 
Lancaster et al., 2017), cerebral organoids provide access to human cortical-like 






However, as cerebral organoids follow species-specific developmental time, it takes a 
longer time to grow human cerebral organoids compared to mouse cerebral organoids. 
Therefore, generating human cerebral organoids is time-consuming and costly; hence 
mouse cerebral organoids could be considered to be more advantageous, especially 
for optimisation and exploration studies. Furthermore, much of our knowledge in 
cortical development is derived from mouse models, thus enable us to compare them 
to cerebral organoid system following genetic manipulation. Therefore, this study 
focuses on cerebral organoids derived from mouse ES cells.  
 
1.2.1 Serum-free embryoid bodies with quick reaggregation (SFEBq) 
protocol  
	
One of the earliest described techniques for producing cerebral organoids is the 
serum-free embryoid bodies with quick reaggregation (SFEBq) protocol, a technique 
that follows the key concepts of telencephalic development (Figure 1.4, Eiraku et al., 













Figure 1.4 Scheme illustrating the main stages of the SFEBq protocol for 














In this technique, an optimised number of aggregated cells are cultured in a serum-
free medium. A controlled number of starting ES cells is essential, as local cell-cell 
interaction influences differentiation potential, as well as cell specification (Valamehr 
et al., 2008). The cells were cultured in a serum-free medium, as serum contains 
highly variable and poorly defined components that triggers spontaneous 
differentiation of ES cells (Ying et al., 2003). Furthermore, serum-free medium 
triggers the intrinsic, default pathway, promoting neural induction (Watanabe et al., 
2005). Among various serum-free media, Knock-out Serum Replacement (KSR) 
medium has been shown to better support cell growth in suspension, and induce 
telencephalic differentiation efficiently without concurrent induction of mesodermal 
and endodermal tissues (Watanabe et al., 2005). In addition, the medium is 
supplemented with external signalling molecules, such as IWP2 (a Wnt inhibitor) to 
protect the cells from caudalising signals (Wnt), thus directing them toward 
telencephalic specification. This is consistent with the principles of telencephalic 
development in vivo that highlight the influence of morphogens in region 
specification. Following neural induction, the aggregates form NE structures that rely 
on structural support provided by the extracellular matrix (ECM), which forms the 
basement membrane (Nasu et al., 2012). 
 
This method was later refined by replacing KSR with a defined chemical medium, for 
a more stable culture. This is due to variation when different lots of KSR supplement 
are used that could affect cortical differentiation efficiency. However, studies have 
shown that organoid batch variation persists even within the same lot of KSR - 
suggesting other contributing factors to batch variation, which are likely intrinsic 




Nevertheless, this system is highly versatile, as regions of the forebrain can be 
specified by modulating external signalling molecules. For example, the cells are 
directed towards telencephalic fate by inhibiting caudalising signals such as Wnt, and 
ventral telencephalic fate can also be induced by controlling the addition of Shh (Nasu 
et al., 2012). 
 
1.2.2 Cortical development in mouse cerebral organoids 
 
Using the SFEBq method, mouse ES cells can form cerebral organoids that 
recapitulate embryonic cortical development. Around day three of culture, the cells 
self-organise into neuroepithelium-like (NE) structures surrounding lumen. This 
tissue demonstrates apico-basal polarity, characterised by the expression of apical 
markers such as N-cadherin, aPKC and ZO-1 on the apical side of the tissue, and 
laminin on the basal side (Figure 1.5A, Eiraku et al., 2008; Nasu et al., 2012). By day 
eight, the NE structures express one of the earliest telencephalic markers, Foxg1 
(Figure 1.5B) and show remarkable resemblance to embryonic cerebral cortex as they 
consist of cells expressing cortical progenitor markers, arranged in the correct pattern 















Figure 1.5 Characteristics of mouse cerebral organoids. (A) A cross-section 
of NE show its expression of aPKC and laminin, suggesting apico-basal 
polarity (B) expression of Foxg1, a telencephalic marker (C) expression of 
reelin and Calretinin, characteristic of Cajal-Retzius cells (D) and cells 
expressing key cortical markers (Pax6, Tbr2, Tbr1) in the correct apico-basal 








For instance, cells of the outermost part of the NE express reelin, a molecular marker 
of Cajal-Retzius cells, which form the first layer of cortical plate (Figure 1.5C). There 
are also cells expressing apical progenitor marker, Pax6 at the apical side of NE, 
forming a layer resembling the ventricular zone (VZ). On top of this layer, there are 
cells expressing Tbr2, a marker characteristic of basal progenitor cells, which form 
another layer resembling subventricular zone (SVZ). This is followed by the 
formation of neuronal cells expressing Tbr1, an early marker of deep layer neurons. 
Furthermore, functional analysis by live imaging shows that apical progenitors of 
organoids (Pax6+) move in an apico-basal direction, characteristic of interkinetic 
nuclear migration (IKNM), a hallmark of cortical development (Nasu et al., 2012). 
 
Therefore, at day eight, cerebral organoids form polarised NE structures containing 
cells expressing key cortical progenitor markers, organised in the same spatial 
arrangement as embryonic cerebral cortex (Nasu et al., 2012). This demonstrates the 
existence of a cell-intrinsic programme for early cortical development. 
  
1.2.3 Limitations of cerebral organoids 
 
Despite the remarkable resemblance of cerebral organoids to the embryonic cerebral 
cortex, it should be noted that the later stages of cortical development are not 
reproduced accurately in organoids, because the neurons fail to recapitulate the 
inside-out arrangement cortical layers (Nasu et al., 2012). For example, at day 12, 
more cortical cell types are detected in the NE, such as cells expressing Tbr1 and 
Ctip2, characteristic of early cortical plate, as well as Cux1+ and Brn2+ cells, 




were born in the correct temporal order, as well as forming multiple layers 
characteristic of early and late cortical plate, their lamination is not in the correct 
inside-out pattern, and separation between them is rudimentary (Nasu et al., 2012) 
 
These limitations might be due to many factors, such as the limited supply of nutrients 
and oxygen to the core of the organoids (which leads to apoptosis and a necrotic 
centre), the absence of vascularization, and the lack of other supporting cells such as 
microglia. Ultimately, there is a limited understanding of mechanisms of organoid 
development, which might limit the accuracy or application of this model as a tool to 
investigate forebrain development. A comparison between in vitro and in vivo 
models, both in control and mutant conditions may fill the gap in our understanding of 
















1.3 Aim of thesis 
 
Despite rapid development in the organoid field, very few studies have reported the 
use of mouse cerebral organoids, and little is known about the molecular machinery 
of this 3D in vitro system. Our current comprehensive understanding in mouse 
corticogenesis, together with the widely characterised roles of Pax6 in normal 
forebrain development, as well as thorough descriptions of Pax6 mutant mouse 
phenotypes, provides a basis to understand how accurately mouse cortical 
development and Pax6 function can be recapitulated in mouse cerebral organoids. 
Furthermore, our understanding of the extent of this 3D model as a tool for 
investigating forebrain development remains fragmentary. 
 
Therefore, this study aims to determine whether cerebral organoids can be used as a 
valid model to study mouse forebrain development. We hypothesised that if cerebral 
organoids develop using the same mechanisms as mouse cortical development, the 
effects of loss of Pax6 in vivo can be reproduced in this 3D system. Therefore, this 
will be addressed by comparing normal and mutant Pax6-/- mouse cerebral organoids 
to the established characteristics of their in vivo counterparts. First, a 3D protocol 
based on the SFEBq method was established and the robustness of the method to 
generate Foxg1+ NE structures was demonstrated. Then, the characteristics of 
organoids under normal conditions were analysed and used as a baseline in the 
analysis of Pax6-/- cerebral organoids. 
 
Once the phenotypes of Pax6-/- cerebral organoids were identified, the cell cycle 




knock-out (cKO) condition was compared to the cortical progenitors of Pax6 cKO 
mice. To address this, new lines of ES cells from Pax6 cKO cerebral organoids were 
established and characterised. This model enables acute Pax6 deletion in a cortex-



































CHAPTER 2: MATERIALS AND METHODS 
 
2.1 Propagation and maintenance of embryonic stem cells 
 
Mouse embryonic stem (ES) cells lines; Foxg1::Venus line with Foxg1 reporter 
(formerly known as Bf1::Venus, Eiraku et al., 2008) and an established Pax6-/- ES cell 
line (Quinn et al., 2010), were cultured in a standard ES medium, GMEM (BHK-21) 
basal medium supplemented with 1 mM Sodium Pyruvate, 2 mM Glutamax, 1x non-
essential amino acid, 0.1 mM β-mercaptoethanol, 10% fetal calf serum (FCS) and 
1:1000 Leukemia Inhibitory Factor (LIF). The cells were incubated at 37°C in 5% 
CO2. All cell culture reagents were obtained from Invitrogen, Thermoscientific, 
unless otherwise stated. 
 
Newly established ES cell lines; Emx1-Cre ERT2; Pax6fl/fl; RCE and Emx1-CreERT2; 
Pax6+/fl; RCE ES cells (described in detail in section 2.10) were maintained in the 
same medium supplemented with 0.5 µM PD 0325901 (Axon medchem).  
 
Cultures were maintained in T25 flask (Corning) coated with 0.1% gelatin. Porcine 
gelatin (1%) was prepared by dissolving 1 g gelatin (Sigma) in 100 ml 1 x PBS 
(Phosphate buffer saline) on a hotplate on medium setting. Prior to use, 0.1% gelatin 
was prepared by diluting 5 ml of 1% gelatin in 45 ml PBS.  
 
Every other day the cells were passaged by trypsinisation with Tryple (trypsin 
replacement). Prior to trypsinisation, medium was aspirated and the cells were washed 




detached, 9 ml fresh medium was added and the cells were further disassociated by 
gentle trituration. The cell suspension was split in 1:10, where 1ml of the cell 
suspension was pipetted into a new flask, and 4 ml of fresh medium was added. 
 
Cells were cryopreserved by preparing cell suspension, followed by centrifugation at 
250 x g for 5 minutes. The supernatant was discarded and the cell pellet was 
resuspended in 1 ml freezing medium, which is the standard ES medium 
supplemented with additional 10% FCS and 10% DMSO. The cells were transferred 
into a cryovial, slowly frozen at -80°C overnight and transferred to liquid nitrogen 
tank for long-term storage. To revive the cryopreserved cells, they were thawed in 
waterbath (37°C) and resuspended in 9 ml medium, followed by centrifugation at 250 
x g for 5 minutes. The supernatant was decanted and the cell pellet was resuspended 
in a fresh ES medium before plated in a gelatin-coated flask. Medium was changed 
the day after. 
 
2.2 Derivation of Pax6 conditional knock-out embryonic stem 
cells 
 
ES cell lines were established following a published protocol (Czechanski et al., 
2014). They were derived from blastocysts obtained from the parental cross of a male 
mouse carrying Emx1-CreERT2 allele (Kessaris et al., 2006), green fluorescent protein 
(GFP) reporter allele (Sousa et al., 2009) and homozygous for a conditional (floxed) 
Pax6fl allele (Simpson et al., 2009), with a female mouse heterozygous for Pax6fl 




Animals (Scientific Procedures) Act 1986 and Edinburgh’s University Animal Ethics 
Committee.    
 
A day prior to blastocyst collection, four-well plates (Falcon) were coated with 0.1% 
gelatin (Sigma) and inactivated mouse embryonic feeder (MEF) cells (Invitrogen). 
MEF cells were cultured in MEF medium containing DMEM-high glucose with 10% 
FCS, 2 mM Glutamax and 1% penicillin-streptomycin. The next day, the feeder cells 
were washed with PBS and the medium was changed to serum-free (2i/LIF) medium. 
 
At day 3.5 post-coitum, the uterus of the pregnant mouse was removed and cleaned of 
fat. Both uterine horns were then flushed with M2 medium (Millipore) using a 5 ml 
syringe attached with 27-G needle, into a petri dish. Subsequently, the flushed 
blastocysts were collected using a mouth pipette and washed in several drops of M2 
and finally plated on a 4-well plate coated with MEF, in serum-free medium. The 
embryos were left undisturbed for 48 hours in the incubator at 37°C, 5% CO2.  
 
After 48 hours, the blastocysts were checked to determine whether they had hatched 
and attached to the plates. The medium was then changed every other day and the 
outgrowths were monitored daily. Prominent outgrowth was then treated with 100 µl 
of 0.05% trypsin and disaggregated vigorously using a mouth pipette. Then, defined 
trypsin inhibitor was added to deactivate the trypsin and the cells were transferred into 
new 4-well plates coated with MEF, in serum-free medium. The cells were now 
recorded as passage one and incubated at 37°C, 5% CO2. After formation of ES 
colonies, they were subcultured with Accutase and gradually maintained in feeder-








ES cells carrying Emx1-CreERT2, RCE and homozygous for the Pax6fl allele were 
genotyped by PCR (Mi et al., 2013a). Briefly, DNA was prepared from ES cells, 
collected at confluency. Cells were lysed with 75 µl lysis buffer (25mM NaOH, 0.2 
mM EDTA) at 95°C for 30 minutes and rested on ice for 5 minutes. Then, 75 µl 
neutralizing buffer (40 mM Tris-HCL) was added to stop the reaction and ready to 
use for PCR to detect allele of interest. 1.5 µl of the DNA was amplified with 0.5 mM 
primer mix in a standard 25 µl PCR reaction (0.5 mM DNTP mix, 1x PCR buffer, 
5U/µl Taq DNA polymerase (Promega). The size of the PCR products (195 bp were 
homozygous for the floxed Pax6 allele, and 156 bp were heterozygotes) determined 
using electrophoresis on a 2% gel. 
 
2.3.2 Immunocytochemistry 
Cells were fixed with 4% PFA for 10 – 20 min at room temperature. Fixative was 
washed off with PBS for 10 minutes, three times. Cells were permeabilized in 
blocking buffer for 30 minutes at room temperature, followed by incubation with 
primary antibodies at 4°C, overnight. The next day, cells were washed with PBS for 5 
minutes at room temperature, three times. Secondary antibodies were then added and 
left at room temperature for one hour. Finally, cells were counterstained with DAPI 






Cells were passaged the day before in 10 ml medium, in a T25 flask. Approximately 
18 hours after the passage, 100 µl colcemid (final concentration:100 ng/mL) was 
added to the flask. After 2-2.5 hours, culture medium from the flask was collected in a 
15ml centrifuge tube and the cells were detached using TrypLE. A cell suspension 
was prepared using the previously collected old culture medium and centrifuged at 
800 rpm for 8 minutes. Supernatant was then decanted, leaving the cell pellet in 1 ml 
residual medium. Next, 9 ml of 0.075M KCL was added slowly to swell the cells 
while the tube was vortexed at low speed and then incubated at 37°C for 20-25 
minutes.  
 
The cells were then fixed with Carnoy’s fixative (3:1 ratio of methanol:glacial acetic 
acid) by adding the fixative gradually, whilst the tube was vortexed. Firstly, three 
drops of fixative was added and the fixative was discarded as the cells were 
centrifuged at 800 rpm for 8 minutes. The steps were repeated with 3 ml, 2 ml and 1 
ml of fixative. Finally, the cells were resuspended by vortexing in a few drops of 
fixative. Finally, 40-50 µl of the cell suspension was dropped on to superfrost slides, 
and left on the bench to air-dry. Vectashield hard set with DAPI was then dropped to 
the slides to stain the chromosomes, and a coverslip was applied. The slides were 
imaged at 40x magnification and at least 20 chromosome spreads were analyzed by 
counting the total number of chromosomes. The percentage of metaphase spreads 





2.3.4 Mycoplasma test 
 
Mycoplasma testing was performed by tissue culture services at the Scottish Centre 
for Regenerative Medicine using Mycoalert mycoplasma testing kit (Lonza). 
 
2.4 Cerebral organoid culture 
 
Cerebral organoids were generated from the aforementioned mouse ES cells, using a 
modified SFEBq protocol. Instead of using chemically defined medium as described 
in the SFEBq protocol, this study used neural induction medium known as knockout 
serum replacement (KSR) medium in the beginning of cerebral organoids culture. ES 
cells were disassociated into single cells and resuspended in KSR medium, containing 
GMEM (BHK-21) medium supplemented with 10% KSR, 1 mM Sodium pyruvate, 
0.1 mM non-essential amino acid, 0.1 mM β –mercaptoethanol and 2.5 µM IWP2 
(Sigma). A total of 5000 cells were plated into each well of U-shaped 96 well plates 
(Sumitomo Bakelite), and this was counted as day zero. Following overnight culture, 
the cells formed an aggregate and were embedded with 200 µg/ml Matrigel (Corning), 
then incubated at 37°C, 5% CO2. Prior to use, Matrigel was thawed on ice for at least 
1 hour, and kept on ice during usage.  
 
On day five, a maximum of 16 organoids were transferred into 50 mm bacterial-grade 
petri dishes (Fisher scientific) in 10 ml cortical maturation medium (CMM), 
containing DMEM/F-12 medium supplemented with 1x N2 and 1x Glutamax. 
Medium was changed every other day by removing half of the medium and 




2.5 Preparation of cerebral organoids for histology 
	
Organoids were collected and transferred into 12 well plates (Greiner) using a 1 ml 
plastic Pasteur pipette. They were washed twice with PBS and fixed with 4% 
paraformaldehyde (PFA) for 15-20 minutes, at room temperature on a shaking 
platform. Finally, the organoids were rinsed with 1 x PBS for 10 minutes, and the 
washes were repeated twice. The organoids were stored at 4°C in PBS until further 
use.  
 
Organoids were then cryoprotected by immersing them in 30% sucrose at 4°C, on a 
rocking platform, overnight. Then, the sucrose was replaced with embedding medium 
(50:50 mixture of 30% sucrose:OCT medium) and left at 4°C, on a rocking platform 
for one hour. Organoids were then transferred into embedding mould and left 
undisturbed for 5-10 minutes, to allow them to settle to the bottom of the mould. The 
remaining embedding medium was removed using p200 pipette and the organoids 
were arranged to the middle of the mould. The mould was then placed on a piece of 
dry ice to fix its position, and was quickly filled with the embedding medium. Finally, 
organoids in the mould were frozen in dry ice and cryosectioned at 10 µm, in a frozen 
microtome chamber (SakuraTek). Cryosections were collected on superfrost slides 
and stored at -20°C.  
 
2.6 Immunohistochemistry  
 
Cryosection slides were brought to room temperature at least 30 minutes prior 




antigen retrieval step was performed by resting the slides in 10 mM citrate buffer for 
5 minutes, followed by heating with microwave for 20 minutes, starting at high 
power. The buffer was checked every five minutes and the power was changed to 
medium/low when the citrate buffer was boiling. Then, the slides were left at room 
temperature (approximately 20 minutes) before being washed with 1x PBS, once. 
Next, the slides were incubated in blocking buffer for two hours and then incubated 
with primary antibody overnight, at 4°C. Primary antibodies were diluted in 10% 





















Table 1. Primary antibodies used 


















GFP Goat 1:400 Abcam ab6673 Yes 
Pax6 Rabbit 1:400 Biolegend  901301 No 
Tbr2 Rabbit 1:200 Abcam ab18399
1 
No 








Sox2 Rabbit 1:200 Abcam ab92494 No 
Tuj1 Mouse 
IgG2a 
1:400 Biolegend 801201 
 
No 
Ki67 Rabbit 1:200 Abcam ab15580 No 



















Pax6 Mouse neat A gift from 













On the second day, the slides were washed three times in PBS, 10 minutes each, 
followed by incubation in secondary antibodies (1:200), diluted in 10% donkey serum 
in PBS, at room temperature.  
 
 
If amplification with streptavidin was required, sections were incubated with species-
specific biotin-conjugated secondary antibodies (goat anti-mouse IgG) instead, for 2 
hours at room temperature. Subsequently, streptavidin-conjugated fluorescent probe 
(1:200) was added to the slides, 30 minutes at room temperature. 
 
Finally, the slides were stained in DAPI diluted in PBS (1:10 000), followed by three 
times washes in PBS, 10 minutes each and finally mounted with VectaShield hard set 
(Vectorlabs) to preserve fluorescence.  
 
2.7 Fluorescent In Situ Hybridisation 
 
Expression of Emx1 was examined by fluorescent in situ hybridsation, following 
protocol as described (Caballero et al., 2014). 
 
2.7.1 Preparation of DIG-labeled probe 
 
Plasmid encoding Emx1 sequence (Simeone et al., 1992) was grown and purified 
following instructions of Midiprep kit (Qiagen). 10 µg of the plasmid was then 





The size of the digested plasmid was then checked by agarose gel electrophoresis 
(1%) at 75V for 1 hour. The linearized plasmid was then purified using a gel 
extraction kit (Qiagen) and the concentration was determined by nanodrop. The cut 
and cleaned plasmid (3 µg) was then labeled with DIG label mix nucleotides (Roche) 
with T7 polymerase and incubated at 37°C for 2 hours. The labeled probe was then 
precipitated overnight at -20°C with 4M LiCl (0.1 vol) and 100% ice-cold ethanol 
(2.5vol). Finally, the probe was pelleted at 12000 x g at 4oC for 20 minutes and the 
supernatant was decanted prior to resuspending it in 25 µl RNase-free water. 
 
2.7.2 Hybridisation procedure 
 
Cryosection slides were warmed to room temperature for up to 30 minutes. A 
humidified box was prepared by lining with tissues soaked in 50% formamide, 0.5x 
salt (10x, prepared as in section 2.7.3.5) and ddH2O topped up to 80 ml. The box was 
then warmed in a 70°C incubator. Emx1 probe was diluted in hybridization buffer 
(1:1000) and denatured at 95°C for 10 minutes, followed by incubation on ice for 5 
minutes. The probe was then added to the slides and incubated in the humidified box 
at 70°C, overnight. 
 
Next day, the slides were washed with wash buffer (pre-warmed) at 70°C for 15 
minutes and the washes were repeated twice, 30 minutes each. Then the slides were 
washed with TNT buffer (pH 7.5) twice, 30 minutes each. Finally, cryosections were 
blocked with TNB buffer prior to incubation with sheep anti DIG-POD (1:1000) in 





On the third day, the slides were washed with TNT buffer (pH 7.5), three times, 5 
minutes each. Biotin-tyramide (1:200) was then added to the slides at room 
temperature, for 10 minutes. The slides were washed with TNT buffer (pH 7.5), three 
times, 5 minutes each and Avidin-Biotin Complex solution (Vector labs) was added to 
the slides at room temperature for 30 minutes. The slides were washed with TNT 
buffer (pH 7.5), three times, 5 minutes each and Cy3 (1:200) was added to the slides 
at room temperature for 10 minutes. Then the slides were washed with TNT buffer 
(pH 7.5), three times, 5 minutes each and counterstained with DAPI. Finally, the 
slides were mounted with VectaShield Hardset. 
 
2.7.3 Preparation of solutions 
 
2.7.3.1 Hybridisation solution 
 





10% 10 x salt 2 
10% Dextran sulfate 50% 2 
1% 100 x Denhardts 0.2 
1 mg/ml 50 mg/ml tRNA 0.4 
50% Deionized formamide 10 
 ddH2O 5.4 











50% Formamide 150 
1x 20x SSC 15 
0.1% Tween 20 0.3 
 ddH2O 135 
TOTAL  300 
 






10% 1 M Tris-HCL pH 
7.5 
0.5 
3% 5 M NaCl 0.15 
5mg/ml Blocking reagent 25mg 
 ddH2O 4.35 
















10% 1 M Tris-HCL pH 7.5 100 
3% 5 M NaCl 30 
0.25% Tween 20 2.5 
 ddH2O 867.50 
TOTAL  1000 
	
2.7.3.5 10x salt 
 
Following reagents were mixed and autoclaved. 
  
Tris-HCL  11.2g 
NaCl 91.2g 
Tris Base 1.1g 
NaH2PO4.2H2O (MW 156) 6.2g 
NaH2PO4  (MW 177) 5.7g 
0.5M EDTA 80ml 







2.7.3.6 20x SSC 
 
Following reagents were mixed, pH adjusted to 5 and autoclaved. 
  
NaCl 175.3g 
Sodium citrate 88.2g 
ddH2O Top up to 800ml 
 
2.7.3.7 Tris-HCL pH 7.5 
 
157.6 g Tris-HCL was added into 1L ddH2O, pH adjusted to 7.5 and autoclaved. 
 
2.7.3.8 5 M NaCl 
 
146.1g NaCl was added to 500 ml ddH2O and autoclaved. 
 
2.8 EdU labeling and detection 
 
For measuring labeling index of EdU cells, 10 mM EdU was added to the culture 
medium at day eight, and collected after two hours. For cumulative EdU labeling 
assay, 10 mM EdU was added to culture medium at day eight, but collected after 2, 4, 
6, 8 and 10 hours. The collected organoids were fixed with 4% PFA and proceeded to 




reaction, following instructions of Click-iT EdU Alexa Fluor 647 Imaging Kit 
(Thermo Fisher Scientific). 
 
2.9 Data analysis 
 






















CHAPTER 3: Pax6-/- cerebral organoids reproduce phenotypes 




Pax6 is one of the best-studied transcription factors of the cerebral cortex that 
regulates many key cellular processes of cortical development. The roles of Pax6 in 
corticogenesis have been discovered mainly from Pax6 loss-of-function mice 
(Pax6Sey/Sey, Hill et al., 1991), where loss of Pax6 causes defects in cortical 
proliferation, differentiation, cell specification, cortical patterning and neuronal 
migration (Ypsilanti and Rubenstein, 2016). The well-established role of Pax6 in 
cortical development provides a basis to compare and contrast its role between 
cerebral organoids to the in vivo system. 
 
Although studies have shown that cerebral organoids recapitulate species-specific and 
unique characteristics of cortical development, the extent to which this system 
recapitulates developmental regulatory mechanisms of cortical development, such as 
Pax6 is still unknown. Furthermore, there is a limited understanding of the 
mechanisms underlying organoid development, raising concerns regarding the 
accuracy of this system as an alternative model for forebrain development. 
 
This chapter aims to compare phenotypes of Pax6-/- cerebral organoids to the 
established phenotypes of Pax6sey/sey mouse.  We hypothesise that if cerebral 




development in the embryos, the Pax6-/- cerebral organoids would share the same 
phenotypes as the Pax6sey/sey mouse. 
 
This chapter begins with the establishment of a robust 3D culture protocol that 
generates cerebral organoids with neuroepithelial-like (NE) structures. For this 
purpose, the same type of cells employed in the SFEBq protocol were used, which is 
the Bf1::Venus ES cells. This transgenic ES cell line was generated by fusing Venus, 
a mutated form of green fluorescent protein (GFP), into the Bf1 gene locus (also 
known as Foxg1), one of the earliest telencephalic markers. Therefore, this ES cell 
line reports on the expression of Foxg1, which will enable us to assess the 
telencephalic differentiation efficiency of our 3D culture protocol. In SFEBq, 
Bf1::Venus (hereafter referred to as Foxg1::Venus) ES cells demonstrate a highly 
reproducible formation of NE structures with efficient differentiation of cells 
expressing Foxg1 (Eiraku et al., 2008). Hence, by using the same starting ES cell line, 
we anticipate similar or better outcomes with our 3D culture protocol.  
 
Next, we applied the 3D culture protocol to generate mutant cerebral organoids from 
an established Pax6-/- ES cell line derived from Pax6SeyEd/SeyEd blastocysts (hereafter 
referred to as Pax6-/-, Quinn et al., 2010). This cell line has been demonstrated to have 
stable neural differentiation, which is not affected by the loss of Pax6. For example, 
early neural differentiation of these cells into embryoid bodies (EBs) showed 
comparable proportions of progenitors and neuronal cells, to the control (Quinn et al., 
2010). Furthermore, they contributed well in chimaeras, thus are capable of 
contributing to cortical tissue in vivo. Therefore, we expect that these mutant lines can 






3.2.1 Establishment of a robust 3D culture protocol  
 
Building on the SFEBq protocol with few modifications, we have successfully 
established a 3D culture method that generates cerebral organoids with robust 
neuroepithelial-like (NE) structures (Figure 1.4). 
 
Firstly, ES cells were cultured in a KSR medium supplemented with IWP2, a Wnt 
inhibitor, to drive the cells towards cortical differentiation (Watanabe et al., 2005).  
Twenty-four hours after plating, the ES cells formed an aggregate (Figure 3.1A), at 
which point Matrigel was added. We then observed protruding structures on the next 
day, followed by the formation of bright and translucent radial structures known as 
NE structures (indicated by arrowheads) from day 3-4 of culture (Figure 3.1B-D). 















Figure 3.1 Early development of cerebral organoids. (A) Formation of 
spherical aggregates with smooth edges at day one (B) Aggregates lose the 
smooth edges and show protruding structures at day two, indicated by arrows. 
(C,D) NE-like structures start to form at day 3-4, indicated by arrowheads. 







To examine the types of cells and tissues present, day eight cerebral organoids were 
sectioned and stained with various markers; starting with N-cadherin, a 
neuroepithelial marker that marks the apical side of neuroepithelium. Day eight 
organoids correspond to an early stage of corticogenesis; approximately E11.5-E12.5 
in vivo. This estimation is based on the approximate equivalence of ES cells to E4.5 
blastocysts (Boroviak et al., 2014). At this stage, we found that there were multiple 
NE structures in our organoids, and they were identified by the presence of lumen. 
These NE structures expressed N-cadherin on the apical surface, which is next to the 
lumen (Figure 3.2). This demonstrates the apico-basal polarity of these structures, 





















Figure 3.2 Cerebral organoids showed formation of polarised NE 
structures. (A) NE structures expressed N-cadherin on their apical surface 
(B) Higher magnification of the boxed area in panel A, showing clear polarised 
















A previous study has reported that the SFEBq method is highly reproducible, with 
more than 95% of the organoids forming NE structures (Eiraku et al., 2008). To 
assess the reproducibility of our 3D culture protocol, NE structures of day eight 
organoids were examined in histological sections and image analysis was performed 
using Image J. Firstly, NE structures were delineated using the freehand selection 
tool; NE structures were defined by tissues with lumen structures, therefore analysis 
was restricted on this selection criterion. We then determined the proportion of NE 
area (excluding the lumen) from the total area of the organoid. We found that 
organoids from all three batches formed NE structures, and on average these 






















Figure 3.3 Quantitative analysis of the proportion of NE area in 
organoids. (A-C) Representative images of cerebral organoids delineated 
with NE from batch 1 – 3. (D) Mean proportion of NE area (± standard error of 
the mean) of 5 organoids from 3 independent batches, (One-way ANOVA, 










It is also reported that organoids generated using SFEBq method show an efficient 
telencephalic induction (65-75%), based on Foxg1 expression (Eiraku et al., 2008). 
This percentage was derived by flow cytometry, which requires cell disassociation, 
and therefore compromising the spatial information of organoids. To retain the spatial 
information of the 3D-organoids, we used histological sections to determine the 
expression of Foxg1 in the NE structures, followed by image analysis using ImageJ. 
Day 8 cerebral organoids derived from Foxg1::Venus ES cells were immunostained 
with GFP to detect the expression of Venus, and the proportion of NE area expressing 
Venus (excluding lumen) from the total area of NE in blue (DAPI) was measured. We 





















Figure 3.4 Quantitative analysis of the NE area expressing Venus 
(Foxg1) (A-C) Representative images of cerebral organoids labelled with GFP 
(Foxg1) from batch 1 – 3. (D) Mean proportion of GFP-positive area in the NE 
structures (±standard error of the mean) of 5 organoids from 3 independent 









3.2.1 Cerebral organoids recapitulate embryonic cerebral cortical 
cytoarchitecture 
 
Prior to neurogenesis, the mouse cerebral cortex mainly consists of neuroepithelial 
(NE) cells that divide symmetrically, maintaining the neural stem cell pool (Noctor et 
al., 2004). As neurogenesis commences (~E10.5), NE cells transform into progenitor 
cells known as radial glial (RG) cells, which mainly divide symmetrically during 
early neurogenesis. As neurogenesis progresses, RG cells also divide asymmetrically, 
giving rise to basal progenitors or neurons (Greig et al., 2013). These cells 
subsequently form progenitor and neuronal layers in an apico-basal organisation 
(Taverna et al., 2014).  
 
To examine whether NE structures of cerebral organoids form organised progenitor 
and neuronal layers, cerebral organoids from early to late stage of development (day 
5, 8, 10 and 12) were labelled with the neural stem cell/progenitor marker, Sox2, and 
the post-mitotic neuronal marker, Tuj1.  
 
At day five, the NE structures consisted of a homogenous population of cells 
expressing Sox2, with very few neurons detected (Figure 3.5A). More neurons were 
identified on day eight, surrounding the basal side of the NE and forming a thin layer 
(Figure 3.5B). However, these layers were difficult to delineate during later stages of 
organoid development (day 10, 12), as the progenitors and neuronal cells mixed with 
each other and lost their organisation (Figure 3.5C,D). This was consistent in every 




































Figure 3.5 Comparison between progenitor (Sox2+) and neuronal (Tuj1+) 
layers in day 5, 8, 10 and 12 cerebral organoids. (A) NE formed a single 
layer of Sox2+ progenitor cells at day five. (B) More neuronal cells appeared 
at day eight, forming neuronal layer on top of the progenitor layer. (C-D) 
Progenitor and neuronal layers were poorly organised at day 10. (D) Layers 







Regional identities in the cerebral cortex can be identified either by their 
morphological structures, which is guided by developmental axes, or by the 
expression of specific molecular markers. As cerebral organoids lack developmental 
axes, a combination of molecular markers is important to determine the identity of NE 
structures (Renner et al., 2017). To examine the cortical identity of NE structures, day 
eight cerebral organoids were stained with a combination of molecular markers 
expressed in the cortex such as Pax6, Tbr2, Tbr1, and Emx1. We found that the NE 

























Figure 3.6 NE structures of cerebral organoids mimic cortical 
cytoarchitecture of the E12.5 cerebral cortex. (A, A’) Pax6 is expressed by 
cells located at the apical surface, followed by (B, B’) cells expressing Tbr2, 
which forms an intermediate layer. (C, C’) Tbr1 is expressed by cells on top of 
the intermediate layer, characteristic of early born neurons, and (D, D’) Emx1 
is expressed throughout the cortex. Scale bar A,B,C,D: 100 µm; A’,B’,C’,D’: 





















Taken together, the established 3D protocol shows generation of cerebral organoids 
with reproducible formation of NE structures and efficient generation of cells 
expressing Foxg1. These NE-like structures demonstrate cortical-like characteristics, 
based on the expression of key cortical markers in the correct organisation, and 
therefore recapitulate cellular aspects of embryonic cerebral cortex cytoarchitecture in 
vivo.  
 
3.2.3 Formation of Pax6-/- cerebral organoids in 3D culture 
 
Establishment of a robust 3D protocol has allowed us to generate Pax6-/- cerebral 
organoids and to compare characteristics of their cortex-like structures to Pax6-/- mice 
embryonic cortex, particularly during the early stages of corticogenesis (E11.5-
E12.5). This period is fundamental in proper cortical function, as the balance of 
proliferation and neurogenesis is tightly coordinated to generate a diverse population 
of neurons, which ultimately form functional neuronal output (Tan and Shi 2013). 
Furthermore, we have shown that spatial information is lost at later stages of organoid 
development (Figure 3.5) suggesting that they are likely to model early stage 
corticogenesis most accurately. 
 
At day eight, Pax6-/- cerebral organoids formed polarised NE structures, identified by 
the expression of N-cadherin on the apical side (Figure 3.7A). Furthermore, the 
progenitors and neuronal cells were organised in an apico-basal order, with the 
progenitors lining the apical surface of NE and form progenitor layer; followed by 








Figure 3.7 Pax6-/- cerebral organoids show polarised NE structures and 
an organised layer of progenitors and neuronal cells. (A) Expression of N-
cadherin on the apical surface of NE (B) Formation of multiple layers of 

















To confirm inactivation of Pax6, its expression was examined by labelling the 
organoids with Pax6 specific antibody. Indeed, expression of Pax6 was not detected 
in the organoids (Figure 3.9). As we are interested in the roles of Pax6 in the cortical 
structures of cerebral organoids, cortical characteristics of the NE structures were 
examined by the expression of genes associated with corticogenesis, such as Tbr2 and 
Tbr1. We found that these markers were expressed by most of the NE structures, 









Figure 3.8 Pax6-/- cerebral organoids express genes associated with 
cortical development, comparable to control. (A-C) Expression of Pax6, 
Tbr2, Tbr1 in the control organoids, (A’) NE structures of Pax6-/- cerebral 
organoids lack Pax6, but maintain the expression of (B’) Tbr2 and (C’) Tbr1.  





3.2.4  Cortical structures of Pax6-/- cerebral organoids show an increase 
in mitotic cells away from the lumen 
 
One of the features of the cerebral cortex is that radial glial (RG) cells undergo 
interkinetic nuclear migration (IKNM); in which the nuclei migrate in an apico-basal 
direction following cell cycle phases (Lee and Norden, 2013). For instance, the cells 
will be at the basal position during S-phase, and then move towards apical surface to 
enter mitosis and subsequently divide (Taverna et al., 2014). In Pax6-/- mice, there is 
an abnormal increase in the proportion of RG cells dividing at non-apical positions, 
suggesting that loss of Pax6 affected the IKNM process (Estivill-Torrus et al., 2002).  
 
There is evidence that cells in the cerebral organoids undergo IKNM (Nasu et al., 
2012). To examine whether loss of Pax6 affected this process and share similar 
cellular defects as mentioned above, both control and mutant cerebral organoids were 
immunostained with mitotic cell marker, phosphohistone H3 (PH3). The number of 
PH3+ cells located 5 or more cells away from the lumen (abventricular) were 
quantified, and the percentage was scored from the total number of PH3+ cells in the 
organoids’ cortical-like structures. Our quantification revealed that the percentage of 
abventricular PH3+ cells at both day 8 and 9 in mutant organoids were higher than the 
control, with a more significant increase at day 9 (Figure 3.9). This is consistent with 
the findings in Pax6-/- mice that showed a more significant increase in the 
abventricular mitotic cells by mid-corticogenesis, suggesting a pronounced defect 






Figure 3.9 Cortical structures of Pax6-/- cerebral organoids show an 
increase of mitotic cells (PH3+) at abventricular position. (A) Day 8 Pax6-
/- cerebral organoids show a higher percentage of PH3+ cells at abventricular 
position than the control, (B) Day 9 Pax6-/- cerebral organoids show a 
significant increase of PH3+ cells at abventricular position than control (mean 
± standard error of the mean; of 10 organoids from 5 independent batches, t-
test, *p<0.05). (C, D) Representative image of control cerebral organoids at 
day 8 and 9, (E, F) Representative image of Pax6-/- organoids at day 8 and 9. 




3.2.5 Cortical structures of Pax6-/- cerebral organoids demonstrate an 
altered labeling index of cells in S-phase 
 
The role of Pax6 in cortical proliferation is well established (Estivill-Torrus et al., 
2002; Mi et al., 2013). Cell proliferation analysis of Pax6-/-  embryos show a higher 
labeling index (LI) of cells that undergo S-phase than control (Estivill-Torrus et al., 
2002). In this analysis, embryos were pulsed with 5-bromo-2'-deoxyuridine (BrdU), a 
thymidine analogue that will incorporate into cells undergoing S-phase.  
 
To examine the role of Pax6 in cortical proliferation of organoids, Pax6-/- cerebral 
organoids were pulsed with 5-ethynyl-2'-deoxyuridine (EdU), an alternative type of 
thymidine analogue.  We then counted the proportion of EdU+ cells in cortical-like 
NE (Tbr2+) to obtain the LI. We found that the LI of the cortical structures (Tbr2+) 
of Pax6-/- cerebral organoids was altered, with a significant decrease in the proportion 
of cells in S-phase compared to control, at day 9 (Figure 3.10). the altered LI suggest 













Figure 3.10 Cortical structures of Pax6-/- cerebral organoids show a 
decrease in the labelling index of cells in S-phase. (A) Day 8 Pax6-/- 
cerebral organoids show a lower percentage of cells in S-phase (EdU+) 
compared to control, (B) Day 9 Pax6-/- cerebral organoids show a significant 
decrease of cells in S-phase (EdU+) compared to control (mean ± standard 
error of the mean; of 10 organoids from 5 independent batches, t-test, 
**p<0.05).  (C, D) Representative image of control cerebral organoids at day 8 
and 9, (E, F) Representative image of Pax6-/- cerebral organoids at day 8 and 




3.2.6 Pax6-/- cerebral organoids show precocious differentiation. 
 
Coordination of proliferation and differentiation is essential to maintain the balance of 
cortical progenitors and neurons, which is key to cerebral cortical function. Therefore, 
proliferation defects in the Pax6-/- mice consequently show precocious differentiation, 
as there is an increase of post-mitotic neurons during early corticogenesis (Estivill-
Torrus et al., 2002; Quinn et al., 2007).  
 
To examine whether Pax6-/- cerebral organoids share the same phenotype, progenitors 
and neuronal cells were labeled with Sox2 and Tuj1, respectively. Compared to the 
control organoids (Pax6+/+), areas containing neuronal cells (Tuj1+) in the NE 
structures of Pax6-/- cerebral organoids appeared to be expanded, and this effect is 

















Figure 3.11 Pax6-/- cerebral organoids show a higher proportion of post-
mitotic neurons than the control. (A,B) Representative images of Pax6+/+ 
and Pax6-/- cerebral organoids labeled with Sox2 and Tuj1 at day 8 (C, D), 






3.2.7 Cortical structures of Pax6-/- cerebral organoids show a non-
significant decrease in the proportion of Tbr2 expressing cells 
 
The Pax6 gene regulatory network is highly complex, with several genes directly 
regulated by Pax6, such as Tbr2. Established studies of Pax6-/- mice have shown that 
the proportion of Tbr2 expressing cells was reduced from as early as E12.5 (Quinn et 
al., 2007).  
 
To investigate this phenotype in cerebral organoids, both mutant and control 
organoids were labeled with Tbr2 antibody and the proportion of cells expressing 
Tbr2 from the total number of cells (DAPI) of the NE structures was quantified. We 
found that although there is a decrease in the proportion of Tbr2-expressing cells in 
mutant cerebral organoids compared to the control at both day eight and nine, this 




























Figure 3.12 Cortical structures of Pax6-/- cerebral organoids show a 
decreased percentage of Tbr2-expressing cells. (A) Day 8 Pax6-/- cerebral 
organoids show a lower proportion of Tbr2+ cells than the control, (B) Day 9 
Pax6-/- cerebral organoids show a lower proportion of Tbr2+ cells than the 
control (mean ± standard error of the mean; of 10 organoids from 5 
independent batches, t-test, p<0.05, n.s). (C, D) Representative images of 
control cerebral organoids at day 8 and 9. (E, F) Representative images of 






Results presented in this chapter demonstrate that mouse ES cells cultured in the 
established 3D culture protocol can form cerebral organoids with robust NE structures 
expressing key cortical markers. Furthermore, this method can be used to generate 
mutant organoids from Pax6-/- ES cells that show similar phenotypes to the Pax6-/- 
mice. 
 
The 3D culture method has allowed the emergence of patterned structures in ES cells 
via self-organisation. Historically, the ability of ES cells to self-organizing was 
discovered by Yoshiki Sasai’s group in their seminal study to generate a 
differentiation protocol with efficient formation of telencephalic precursors (Eiraku et 
al., 2008). Known as the serum-free embryoid bodies with quick reaggregation 
(SFEBq), this method combines suspension culture and serum-free medium – two of 
the principles of organoid culture (3D). This condition allows more freedom for the 
cells to establish interactions and form an aggregate, reminiscent of embryos. Unlike 
embryoid bodies, aggregates from SFEBq mainly consist of neuroectodermal cells 
and lack other cell derivatives of the three germ layers (Watanabe et al., 2005). This 
may be due to the use of serum-free medium, which has been shown to allow ES cells 
to achieve neural induction by default mechanism (Smukler et al., 2006) – consistent 
with the default acquisition of rostral neural fate in vivo (Levine and Brivanlou, 
2007). In addition, this protocol is relatively simple compared to other protocols, as it 
only uses a single signaling molecule in the medium; Wnt inhibitor (IWP2). IWP2 
inhibits Wnt secretion via Porcupine (Porcn), therefore only endogenous Wnts are 




further supports formation of telencephalon, a rostral part of the brain (Suzuki and 
Vanderhaeghen, 2015). Indeed, supplementation with this small molecule has been 
shown to increase the efficiency of cortical differentiation (Nasu et al., 2012). 
 
3.3.1 Cerebral organoids show reproducible formation of 
neuroepithelium structures expressing Foxg1 
 
Similar to the findings of SFEBq, here we show that our 3D culture provides a 
permissive environment for the ES cells to make cell-cell interactions, subsequently 
forming an aggregate. Moreover, they can self-organise and form NE structures, 
characteristic of an organoid culture (Nasu et al. 2012). Most importantly, this 
protocol is reproducible, demonstrated by the formation NE structures in all of the 
cerebral organoids from different types of ES cells; Foxg1::Venus, Pax6-/- and Pax6 
conditional knock out (cKO) ES cells (chapter five).  
 
Structural and spatial features of organoids can be analysed in whole mount, using a 
combination of tissue clearing techniques and advanced microscopy – such as light-
sheet microscopy. However, due to the lack of developmental axes, organoid analysis 
requires multiple molecular markers for tissue identification, which is a limitation in 
whole mount analysis if there are no compatible antibodies available (Renner et al., 
2017). Therefore, the organoids were analysed in histological sections, a classic 
approach used in analysing mouse embryos, including embryonic brain. This 
technique is useful in revealing the NE structures, allowing a more detailed analysis 
of the organoids. To minimise the underestimation of NE structures due to random 2D 




collected on multiple slides. Around 6-8 sections can be collected in a single slide, 
with the first and the last two sections being smaller sizes, as they were cut from the 
top and bottom end of the organoids. As such, these sections usually show shorter NE 
structures with smaller lumens, like the neural rosettes. Therefore, sections that were 
cut from the middle part of organoids (sections 4-5) are usually more elaborate and 
suitable for analyses.  
 
NE structures are the key feature of cerebral organoids, and also an indicator of self-
organisation of ES cells in 3D culture. Interestingly, these structures are varied in 
shapes and size, thus making each organoid unique. Heterogeneity has been described 
as one of the inherent limitations of organoid culture, possibly due to their self-
organising mechanism (Bredenoord et al., 2017; Quadrato et al., 2017). This 
heterogeneity is more evident between different batches, as demonstrated in our 
quantitative data (Figure 3.3). We show that between the three batches of organoids; 
two of them are comparable in terms of the proportion of NE (area), with 43% and 
47%, respectively. This estimation seems to reflect the analysed images accurately. 
This data also suggests that slightly over 50% of the remaining organoids are not NE 
structures. These remaining areas could include lumen, cells surrounding the NE and 
cells at the core centre. Given the limited space and nutrients, the majority of cells in 
the organoids core centre do not form any particular organisation. Unlike in vivo 
tissue, organoids lack vascularisation, which limits diffusion of nutrients to the core, 
resulting in a necrotic centre (Giandomenico et al., 2018; Renner et al., 2017). On the 
other hand, cells surrounding NE are likely to be non-cortical cells, as several findings 




molecular markers as they often lack structural pattern (Lancaster et al., 2013; Renner 
et al., 2017).  
 
In addition to the reproducible formation of NE, we also show that 60-70% of the NE 
area expressed Foxg1, one of the markers that specify telencephalic region. The 
efficient generation of Foxg1+ NE structures could be the result of Wnt inhibition in 
our 3D culture, which drives the organoids towards more rostral-part of the brain 
(telencephalon). This indicates that the endogenous programme of organoids can be 
manipulated according to the principles of forebrain development established from 
animal models.   
 
3.3.2 Corticogenesis in cerebral organoids. 
 
The cerebral cortex consists of heterogeneous population of cortical cells that can be 
identified by the expression of molecular markers, as well as the position of the cells 
in the cortex. For example, cortical progenitors form a germinal layer at the apical 
side of the cortex, demarcated by the expression of Sox2 by the progenitors. This 
germinal layer can be further classified into ventricular zone (VZ) and subventricular 
zone (SVZ), which is populated by apical progenitors (Pax6+) and basal progenitors 
(Tbr2+). As these progenitors differentiate, a neuronal layer forms on top of the SVZ, 
characterised by the expression of early neuronal marker, Tbr1, as well as Tuj1, a 
marker for post-mitotic neurons.  
 
Here we show that the NE structures of organoids recapitulate characteristics of the 




the apical localisation of N-cadherin (Figure 3.3), a cell adhesion molecule which is 
highly expressed on the apical end of NE during early corticogenesis (Kadowaki et 
al., 2007). These NE structures started as a single layer of progenitor cells (Sox2+) at 
day five of culture, similar to the neural tube stage. Subsequently at day eight of 
culture, neuronal cells emerge, forming an extra layer that separates the progenitor 
and neuronal zone – similar to the early stage of neurogenesis (E11.5-E12.5). 
However, this organisation of progenitors and neuronal layers was progressively lost 
by day 10 and 12 of culture (Figure 3.6). This is not surprising, given the consensus of 
the limitation of organoids to model later stages of development (Camp et al., 2015; 
Di Lullo and Kriegstein, 2017). Therefore, day eight organoids are more organised 
and could recapitulate cortical cytoarchitecture. Indeed, further characterisation of day 
eight cerebral organoids show that they express molecular markers associated with 
cortical development (Pax6, Tbr2, Tbr1), organised in the correct pattern as observed 
in cerebral cortex (Figure 3.7).  
 
Emx1 is a transcription factor expressed specifically in the cortex, which includes the 
cortical progenitors and neurons (Chan, 2001). Therefore, its expression is restricted 
to the dorsal part of the telencephalon, forming a boundary between dorsal and ventral 
telencephalic regions. We show that Emx1 was also expressed in the NE of cerebral 
organoids, with a few of them expressing Emx1 in an interesting pattern; where one 
half of the NE was Emx1+, and the other half was Emx1-, as shown in Figure 3.7D. 
This creates a sharp boundary between these two halves of the NE, reminiscent of the 
boundaries between dorsal and ventral telencephalon, in vivo. Therefore, the tissues 




lateral part of ventral telencephalon. Further characterisation of the organoids with 
ventral telencephalic markers is thus necessary in future analyses to confirm this. 
 
Taken together, our results suggest that the established 3D protocol successfully 
generate cerebral organoids containing robust telencephalic NE-like structures with 
cortical characteristics. 
 
3.3.3 Roles of Pax6 in the cortical structures of cerebral organoids  
 
By implementing the established 3D culture method, Pax6-/- cerebral organoids were 
successfully generated, which enabled us to compare their characteristics to the 
control organoids. This has provided us with an insight into the roles of Pax6 in 
cerebral organoids, and whether they correspond to the roles of Pax6 in corticogenesis 
in vivo.  
 
3.3.3.1 Pax6 is required in proper cell cycle regulation of cortical 
progenitors in cerebral organoids  
 
Cortical progenitors, particularly radial glial (RG) cells undergo cell cycle regulation 
that affects many aspects of cellular biological processes; such as the balance of 
proliferation and differentiation, as well as cell fate determination (Dehay and 
Kennedy, 2007). During this cycle, cells oscillate in an apico-basal direction as they 
undergo different phases of the cell cycle; for example, the cells undergo M-phase 
(mitosis) at the apical side, and then enter G1-phase as they move basally to enter S-




phase again (Kosodo et al., 2011). This synchronised movement is also referred to as 
interkinetic nuclear migration (IKNM), a hallmark of neurogenesis (Sauer and 
Walker, 1959). 
 
IKNM has been demonstrated in cerebral organoids (Nasu et al., 2012). Interestingly, 
we found that there is an abnormal increase in the proportion of cells undergoing M-
phase (PH3+) away from the apical side (abventricular) in the cortical NE of Pax6-/- 
cerebral organoids, with a more significant increase at day 9 (Figure 3.9). This 
phenotype is similar to the established findings in Pax6-/- embryonic cortex that 
showed an increase in the proportion of abventricular mitotic cells from E10.5 until 
E15.5, with a significant increase in the latter (Estivill-Torrus et al., 2002).  
 
As basal progenitors divide at the basal side of the cortex, therefore co-expressing 
PH3 (Tbr2+,PH3+), it is also possible that these abventricular PH3+ cells are basal 
progenitors. However, previous study has shown that the proportion of Tbr2+ cells 
are significantly reduced in Pax6-/- embryonic cortex, therefore most of the 
abventricular PH3+ cells do not express Tbr2, suggesting the ectopic expression of 
PH3+ (Quinn et al., 2007). Although this could also explain the ectopic expression of 
PH3+ cells in Pax6-/- cerebral organoids, future studies should further characterise 
these PH3+ cells to confirm the role of Pax6 in IKNM of cerebral organoids. 
 
As IKNM coordinates with the cell cycle (Kosodo et al., 2011), the increased 
proportion of abventricular mitotic cells could also indicate an abnormal cell 
proliferation. Indeed, both Pax6-/- cerebral organoids and Pax6-/- embryonic cortex 




these two models are different, as Pax6-/- embryonic cortices demonstrated a higher LI 
than the control, whereas Pax6-/- cerebral organoids showed a lower LI than control 
organoids (Estivill-Torrus et al., 2002).  
 
To explain this discrepancy, further analysis on the cell cycle kinetics is required, as 
higher LI could be due to either rapid cell proliferation, or longer length of S-phase 
(Warren et al. 1999). This has been demonstrated in a more recent study, using a 
cortex-specific Pax6 conditional knock-out (cKO) mice, which enables acute deletion 
of Pax6 in cortex-specific region (Mi et al., 2013). This study revealed that following 
acute deletion of Pax6, cortical cells of rostro-lateral region cycles rapidly, with 
shorter G1 phase; while there is no significant change on cortical cells of caudo-
medial region (Mi et al., 2018; Mi et al. 2013).  
 
Therefore, it is intriguing whether acute deletion of Pax6 in cerebral organoids could 
recapitulate the aforementioned effect in Pax6 cKO mice, and this will be addressed 
in subsequent chapters. In general, it is evident that Pax6 plays an important role in 
cell proliferation in both in vivo and 3D in vitro models. 
 
Proliferation of cortical progenitors is tightly regulated to maintain the correct balance 
of progenitors and neuronal cells, as well as the size of the cortex (Hindley and 
Philpott, 2012). Therefore, changes in proliferation consequently lead to either a lag 
or precocious differentiation of the progenitors, which is evident in the proportion of 
neuronal cells. For example, it is well established that Pax6 plays an important role in 
proliferation, demonstrated by the altered proportion of cells in S-phase as well as the 




2013; Quintana-Urzainqui et al., 2018). Consequently, a higher proportion of post-
mitotic neurons was detected during early corticogenesis of Pax6-/- embryos (Estivill-
Torrus et al., 2002; Quinn et al., 2007). Indeed, a similar phenotype was found in 
Pax6-/- cerebral organoids, suggesting the compatibility of these two systems (Figure 
3.12).  
 
3.3.3.2 Transcription factor Tbr2 may not be regulated by Pax6 in 
cerebral organoids 
 
The pleiotropic functions of Pax6 in telencephalic development suggest the 
complexity of its gene regulatory network.  For example, evidence from E13.5 cortex-
specific Pax6 cKO embryos demonstrated that Pax6 control in cell proliferation is 
region-specific, as changes in cell cycle kinetics were detected only in the rostro-
medial region, where Pax6 expression is the highest (Mi et al., 2013). This finding is 
consistent with the Pax6 gain-of-function study, which suggests the importance of 
Pax6 expression level in proper corticogenesis (Sansom et al., 2009; Georgala et al., 
2011). Furthermore, a more recent study found different roles of Pax6 in cell cycle 
regulation between the cortex and thalamus, possibly regulated by another 
transcription factor, namely Foxg1 (Quintana-Urzainqui et al., 2018). 
 
Tbr2 is one of the direct target genes of Pax6, which is downregulated in Pax6-/- 
embryos (Quinn et al., 2007; Sansom et al., 2009). Tbr2 is a marker for basal 
progenitors, which is sequentially expressed after differentiation of apical to basal 
progenitors, following downregulation of Pax6 (Englund et al., 2005). We have 




cerebral organoids, compared to control, at both day 8 and day 9 (Figure 3.13). 
However, this decrease was not significant. Considering the use of Tbr2 to define the 
cortical region in our analysis, this result could be due to an underestimation of 
cortical regions, as Tbr2 is downregulated in the absence of Pax6 (Quinn et al., 2007). 
Therefore, the use of an alternative cortical marker that is not affected by the loss of 
Pax6 might be a more accurate way to define the cortical region in this mutant, for 
example, Emx1. 
 
Taken together, our results demonstrate comparable phenotypes of Pax6-/- cerebral 
organoids to Pax6-/- embryos. Given the caveats of the results, the following chapter 
will describe the establishment of cortex-specific Pax6 cKO ES cells, which will 
allow us to delete Pax6 specifically in the cortex, at a specific time. This will enable a 













CHAPTER 4: Establishment of cortex-specific Pax6 




The results presented in the previous chapter demonstrated that Pax6-/- cerebral 
organoids reproduced similar phenotypes to E12.5 Pax6-/- embryos. This may suggest 
that Pax6 in these two systems could be operating by comparable developmental 
regulatory mechanisms. Although the labeling index (LI) of EdU+ cells in both 
systems was altered, it is notable that the proportion of cells in S-phase was decreased 
in the mutant organoids compared to the control, which is in contrast to what has been 
found in vivo (Warren et al., 1999). This discrepancy could be due to constitutive loss 
of Pax6, which possibly leads to the accumulation of secondary defects that may 
affect cell proliferation of cerebral organoids. In fact, constitutive loss of Pax6 is 
lethal to embryos, which hampers the study of the role of Pax6 later in development 
(Warren et al., 1999). Additionally, the use of Tbr2 to define cortical regions in Pax6-
/- cerebral organoids may have caused an underestimation in the quantitative analysis, 
as Tbr2 is downregulated in the absence of Pax6 (Quinn et al., 2007).  
 
In vivo, a cortex-specific Pax6 conditional knock out (cKO) mouse model is used to 
circumvent the limitations of the Pax6 constitutive loss-of-function model (Pax6-/-, 
Mi et al., 2013). The Pax6 cKO mouse utilises the inducible Cre-Lox recombinase 
system, which enables acute deletion of Pax6 with spatio-temporal control. The Cre 
recombinase is fused with a mutated estrogen receptor (CreERT2), which is responsive 




CreERT2 is controlled by the Emx1 promoter, driving Cre activity specifically in the 
cortex and constrains Pax6 deletion to this region (Figure 4.1A; Kessaris et al., 2006). 
Therefore, in the presence of 4-OHT, Cre catalyses recombination of loxP sites 
flanking a stop sequence, which activates the downstream EGFP in the RCE:loxP 
allele (Figure 4.1B;Sousa et al., 2009), as well as loxP sites flanking exons 5, 5a and 6 
of Pax6 (Figure 4.1C; Simpson et al., 2009). This results in Pax6 deletion in a cortex-
specific region, which can be monitored by the expression of GFP that reports on 























Figure 4.1 Genetic elements of the inducible, cortex-specific Pax6 
conditional knockout system. Upon treatment with 4-OHT, (A) CreERT2 
allele is activated, which is driven by Emx1 and the activation is reported by 
the (B) RCE allele, with upstream floxed STOP cassette, as well as deletion of 








To date, there are very few studies using conditional mutant organoids, with only one 
study reported in gut organoids, and none in cerebral organoids (Andersson-Rolf et 
al., 2017). Considering that conditional mutants are one of the important tools in 
neurodevelopmental studies, it is therefore imperative to explore their use in cerebral 
organoids. 
 
In order to generate this conditional mutant model, this chapter aimed to derive 
embryonic stem (ES) cells from the cortex-specific Pax6 conditional knock out (cKO) 
mouse (Mi et al., 2013). This will not only allow us to further investigate Pax6 
control in the cortex-specific region of the cerebral organoids, but also will enable us 
to determine the extent to which this model recapitulate the in vivo system by 
comparing the phenotypes of Pax6 cKO cerebral organoids directly to the well-
established phenotypes of Pax6 cKO mice. Furthermore, this model, which contains 
the Emx1-driven Cre reporter, could improve the analysis of cerebral organoids by 
using the expression of GFP as a proxy to identify cortical neuroepithelium-like (NE) 
structures in the organoids – hence reducing the underestimation in quantitative 
analyses. 
 
Pax6 conditional knock out (cKO) mice are maintained on a CD1 background, an 
outbred stock. To the best of our knowledge, derivation of ES cells from this stock 
has not been reported before, thus the ES cell derivation efficiency is unknown 





There are two types of medium widely used for ES cell derivation; the standard ES 
medium with LIF and serum, and the serum-free medium supplemented with two 
small molecule inhibitors, known as 2i/LIF medium. The former medium is used in 
the classic ES cell derivation technique, and it is quite inefficient due to the presence 
of poorly defined components in the serum, promoting spontaneous differentiation. 
Furthermore, ES derivation using this medium is limited to a very few mouse strains 
such as the 129 and C57B1/6 mice, also known as the permissive strains.  Other 
strains are categorised as recalcitrant or non-permissive, as it was difficult to derive 
ES cells from them using this medium (Martello and Smith, 2014; Czechanski et al., 
2014).  
 
However, problems with this classic technique were resolved with the use of 2i/LIF 
medium, which further allows ES cell derivation from recalcitrant strains and species 
(Buehr et al., 2008; Nichols et al., 2009; Reinholdt et al., 2012). This serum-free 
medium employs two small molecule inhibitors (PD0325901 and CHIR99021), which 
are sufficient to maintain ES cell self-renewal as well as preventing spontaneous 
differentiation (Ying et al., 2003). PD0325901 inhibits cell differentiation via the 
MEK/Erk pathway, and CHIR99021 maintains cell proliferation via inhibition of the 
glycogen synthase kinase-3 pathway (GSK3). This culture condition is also known as 
the “ground state” condition, as it maintains ES cells in their ground state of 
pluripotency, equivalent to the early pre-implantation blastocyst, E3.5 (Martin 





As ES cell derivation efficiency from the cortex-specific Pax6 cKO mouse on a CD1 
background is unknown, this chapter describes establishment of the ES cells using 
2i/LIF medium (hereafter referred to as 2i/LIF). 
 
4.2 RESULTS 
4.2.1 Derivation of ES cells from Pax6 cKO mice of CD1 background 
 
To determine whether ES cells can be derived from Pax6 cKO mice of CD1 
background, 2i/LIF medium was used and the derivation efficiency was determined 
by scoring the number of stable ES cell lines over the number of attached blastocyts. 
A total of 24 blatocysts at ~E3.5 were collected from three independent parental 
crossings of Pax6fl/fl; Emx1-CreERT2; RCE males with Pax6+/fl females, and a unique 
number was assigned to each batch (Table 4.1).  
 
Table 4.1 Summary of the established ES lines. 









113 9 8 2 113.1, 
113.2 
114 4 3 2 114.1, 
114.3 






Based on Mendelian inheritance, 50% of the ES cell lines were expected to carry the 
Emx1-CreERT2 allele, with half of them homozygous for the floxed Pax6 allele 
(Emx1- CreERT2;Pax6fl/fl, 25%) and another half heterozygous for the floxed Pax6 
allele (Emx1- CreERT2;Pax6+/fl, 25%). 
 
To assist the attachment of blastocysts, mouse embryonic fibroblast (MEF) were 
successfully propagated one day prior to blastocyst isolation. MEFs formed matrix to 
assist blastocyst attachment, as well as producing growth factors for cell viability 
(Czechanski et al., 2014). Indeed, 88% of the isolated blastocysts were successfully 






Figure 4.2 From blastocyst to ES cells. (A) Blastocyst forms an outgrowth 
at day seven of culture, (B) After disaggregation of the outgrowth, cell 
colonies formed, and later known as (C) ES cell lines, following stable growth 




Following disaggregation of the outgrowth, only 62% of the disaggregated outgrowth 
continued to propagate (n=21, Figure 4.2), while the remainder either failed to grow 
after disaggregation or became contaminated. Therefore, the ES derivation efficiency 
from CD1 mice was 62%, consistent with the efficiency of ES cell derivation from 
recalcitrant strain using 2i/LIF medium, which is around 50-70% (Czechanski et al., 
2014). 
 
Although 2i/LIF condition supports efficient derivation of ES cells, long-term 
maintenance of ES cells in this medium is controversial. There are emerging reports 
of altered epigenome, as well as chromosomal abnormalities in ES cells after 
prolonged culture in 2i/LIF medium (Chen et al., 2015; Choi et al., 2017). Therefore, 
to prevent such consequences, these cells were gradually cultured in a standard ES 
medium (LIF/serum), without feeder cells. The cells were incubated in a mixture of 
2i/LIF: LIF/serum medium, with the ratio of LIF/serum being gradually increased in 
every passage, from 30%, 50%, 70% to complete LIF/serum (100%). During the 
transition period, changes in cell morphology were observed; from a refractile and 
tight colony in 2i/LIF medium to a more heterogenous population of cells; a mixture 
of cells with higher ratio of nuclei to cytoplasm and differentiated cells in the standard 












Figure 4.3 Transition of ES cells cultured in 2i/LIF to LIF/serum medium. 
(A) ES cell colonies cultured in 2i/LIF culture were tightly-packed and 
refractile, (B-D) The colonies became less refractile during the gradual 
increase of LIF/serum medium, (E) Heterogeneous population of cells with 






The presence of differentiated cells in LIF/serum culture might reflect the effect of 
serum showing inevitable spontaneous differentiation, which results in a more 
heterogenous culture.  
	
4.2.2 Characterisation of the ES cell lines genotypes 
 
Following establishment of the ES cell lines, the next step was selecting ES cells with 
the following genotypes: Pax6fl/fl; Emx1-CreERT2; RCE (experimental cells), and 
Pax6+/fl; Emx1-CreERT2; RCE (control cells). Note that the only difference between 
the experimental and control sample was the status of the floxed Pax6 allele, with the 
former being homozygous and the latter being heterozygous for the allele.  
 
Genotyping by PCR was performed, and cell lines with the genotypes of interest were 
further maintained. We found that ~50% of the established ES cell lines (113.1, 
113.2, 114.1, 114.3, 115.7, 115.9) carried the Cre allele (n=13, Figure 4.4A), and out 
of these Cre+ cell lines (n=6), 50% of them were homozygous for the floxed Pax6 
allele (113.1, 114.1, 115.7) and another 50% were heterozygous (113.2, 114.3, 115.9). 
Therefore, three sets of experimental and three sets of control ES cell lines were 







Figure 4.4 Genotypes of the ES cell lines. (A) Six of the cell lines carry the 
Cre allele. (B) Three of the Cre+ cell lines (113.2, 114.1, 115.7) are 
homozygous for the floxed Pax6 allele, and three of the Cre+ cell lines (113.1, 
114.3, 115.9) are homozygous for the floxed Pax6 allele. (C) RCE allele was 
detected in all of the cell lines. M: 100bp, B: negative control, C: positive 
control, 1: 113.1, 2: 113.2, 3: 114.1, 4: 114.3, 5:115.1, 6:115.2, 7:115.4, 




To facilitate the identification of the cell lines to their genotype,  these cell lines were 
renamed as following (Table 4.2).  
 














115 7 115.7 Pax6fl/fl; Emx1-
CreERT2; RCE 
cKOhom1 





1 114.1 Pax6fl/fl; Emx1-
CreERT2; RCE 
cKOhom2 
3 114.3 Pax6+/fl; Emx1-
CreERT2; RCE 
cKOhet2 
113 1 113.1 Pax6fl/fl; Emx1-
CreERT2; RCE 
cKOhom3 












4.2.3 Karyotype analysis and the expression of pluripotency markers  
 
To check chromosomal stability of the selected ES cell lines, their karyotype was 
assessed by counting the number of chromosomes from at least 20 metaphase spreads 
(Figure 4.5A). The percentage of metaphase spreads with 40 chromosomes were 
calculated and cell lines with the score of >60% were considered to be euploid. 
Quantitative analysis showed that four of the six Cre+ ES cell lines were 





Figure 4.5 Distribution of ES cells with different number of 
chromosomes. (A) Representative image of metaphase spread stained with 
DAPI. (B) All ES cell lines showed >60% of the cells with 40 chromosomes 
(normal karyotype), except cKOhet3 and cKOhom3 with <60% of the cells 











































However, cKOhet3 and cKOhom3 lines show <60% normal chromosome count and 
therefore were abnormal (n= 3 batches). It is noted that both of these aneuploid ES 
cell lines were derived from the same batch (#113), and 75% of the blastocysts from 
this batch failed to survive in culture, mostly after outgrowth disaggregation, probably 
due to the instability of the cell line (Czechanski et al., 2014). Therefore, it is possible 
that all of the blastocysts from batch #113 were abnormal from the start, including the 
cKOhet3 and cKOhom3 lines. Taken together, a total of four ES cell lines with 
normal karyotypes were established and further characterised and maintained. 
 
The ES cell gene regulatory network is centred on three core transcription factors, 
Oct4, Sox2 and Nanog. Oct4 is the master regulator of pluripotency, which is 
downregulated upon differentiation and often acts together with Sox2 (Nichols and 
Smith, 2012). However, the mere presence of expression of these genes is insufficient 
to demonstrate pluripotency as it is a dynamic process characterised by heterogenous 
expression of Nanog (Silva et al., 2008; Chambers et al., 2007). Therefore, to assess 
pluripotency of the four karyotypically normal ES cell lines, they were stained with 
Oct4 and Nanog antibodies.  
 
Consistent with the reported expression patterns of Oct4 and Nanog in mouse ES 
cells, almost all of the cells in the four established ES lines expressed Oct4, with 
heterogenous expression of Nanog, which is evident from subpopulation of cells with 












Different levels of Nanog are associated with pluripotency stability, as subpopulations 
with low Nanog were found to be more susceptible to differentiation (Nair et al., 
2015; Kalmar et al., 2009). Nevertheless, this dynamic state of pluripotency is 
inevitable in ES cell culture. Therefore, based on the expression of these hallmark 
pluripotency markers, the established cell lines are considered pluripotent. 
 
ES cell lines were also tested for mycoplasma contamination by the tissue culture 
facility at the Scottish Centre for Regenerative Medicine and were confirmed free 
from mycoplasma (Appendix A). 
 
4.2.4 Pax6 cKO ES cell lines show incomplete aggregation 
 
As mentioned in the previous chapter, the first step in the formation of cerebral 
organoids is cell aggregation (Figure 3.1). An optimal aggregate can be identified by 
its spherical morphology, size, as well as smooth and clear edges. In contrast, a 
suboptimal aggregate is surrounded by visible dead cells, which were possibly 
differentiated cells that unable to aggregate and were therefore unable to survive in a 
serum-free medium. These suboptimal aggregates have fewer aggregating cells, 
resulting in insufficient cell-cell interaction that could affect neural induction, as well 
as cell fate – hence they will usually be discarded, as part of cerebral organoids 
quality control (Lancaster and Knoblich, 2014). 
 
To determine the formation of optimal cerebral organoids in the established ES cell 
lines, equal numbers of cells (5000 cells) were aggregated following the established 




were examined for the presence of cells that were unable to aggregate. Organoids 
from Foxg1::Venus ES cells were used as a control, as they have been used 
previously in the establishment of the 3D protocol and successfully formed optimal 
aggregates, which ultimately showed robust formation of NE structures, as reported in 
the previous chapter.  
 
Interestingly, almost all of the day one aggregates from the established ES cell lines 
exhibited the presence of non-aggregating cells, which has affected their size – 























Figure 4.7 Aggregation of Pax6 cKO ES cells before and after treatment 
of ES cells with PD0325901. (A-D) ES cells without treatment with 
PD0325901 show incomplete aggregation, results in smaller aggregates 
compared to control. (A’-D’) ES cells after treatment with PD0325901 























These non-aggregating cells could be differentiated cells that were unable to survive 
in the serum-free medium. This may be due to the poor ES cell culture, which 























Figure 4.8 Pax6 cKO ES cell lines are more heterogenous.  (A) Control ES 
cell colonies (Foxg1::Venus ES cells) are more compact, with few 
flat/differentiated cells (B) Pax6 cKO ES cell lines show ES colonies with less 
tight colonies and more heterogenous, indicated by the presence of 

















Spontaneous differentiation can be triggered by the poorly defined components in 
serum, as well as from the activation of MEK/Erk kinase, an important pathway in 
cell differentiation (Martello and Smith, 2014). This pathway can be activated by 
FGF4, which is secreted endogenously by ES cells (Kunath et al., 2007). Evidence 
showed that blocking the MEK/Erk pathway in the presence of LIF is sufficient to 
prevent differentiation of ES cells and can rescue a deteriorating culture (Tamm et al., 
2013; Ying et al., 2008; Nichols and Ying, 2006). Therefore, to reduce the proportion 
of differentiated cells in the established ES cell cultures, as well as to rescue the 
undifferentiated ones from differentiating, the ES cell lines were treated with 
PD0325901, a small molecule inhibitor that blocks the MEK/Erk pathway. Indeed, 
this treatment significantly reduced the non-aggregating cells and improved cell 
aggregation, evident from the size of the aggregates, which were comparable to the 
control (Figure 4.8 A’,B’,C’,D’).  
 
Although inhibition of MEK/Erk pathway in a prolonged culture has been shown to 
compromise epigenetic stability and cause aneuploidy, a recent study found that this 
can be prevented with a lower concentration of PD0325901 (Di Stefano et al., 2018). 
Therefore, considering the effects of suppression of MEK/Erk pathway, the ES cells 
were treated with a reduced concentration of PD0325901 (0.5 µM), and only low 








4.2.5 Pax6 cKO ES cell lines form cerebral organoids in 3D culture 
	
Following the establishment of Pax6 cKO embryonic stem (ES) cells, their ability to 
form cerebral organoids with neuroepithelium-like (NE) structures expressing Pax6 
was determined. Cerebral organoids were generated using the established 3D culture 
protocol described in chapter three, collected at day eight of culture and cross-
sectioned to examine the formation of NE structures. To ensure that these organoids 
expressed Pax6 prior treatment with 4-OHT, the sections were labeled with Pax6 
(apical progenitor marker) and Tuj1 (post-mitotic neuronal marker) antibodies.  
 
Figure 4.9 shows that three out of four ES cell lines formed cerebral organoids with 
NE structures expressing Pax6 and Tuj1, except cKOhet2 cell line (n=3). Although 
this suggests variability between cell lines, it also indicates the robustness of the 















Figure 4.10 Formation of NE structures in Pax6 cKO cerebral organoids. 
(A) One of the control cell lines (cKOhet1) form NE structures expressing 
Pax6 and Tuj1, (B) while NE structures are not detected in cKOhet2 cerebral 
organoids. (C, D) Both of the experimental cell lines (cKOhom1 and 
cKOhom2) successfully form cerebral organoids with NE structures (n=3). 












Embryonic stem (ES) cells are pluripotent cells derived from pre-implantation 
embryos and they are the building blocks of cerebral organoids. Results presented in 
this chapter collectively demonstrate the successful derivation of ES cells from 
cortex-specific Pax6 cKO mice on a CD1 background. A total of four ES cell lines 
with the desired genotypes were successfully established, and they retained normal 
karyotypes, expressed pluripotency markers and were free from mycoplasma 
contamination. 
 
4.3.1 Efficient derivation of ES cells from Pax6 cKO mice using 2i/LIF 
medium 
 
One of the ways to probe the cerebral organoid system is by acute removal of an 
important gene in cortical development (e.g. Pax6). Therefore, establishment of 
cortex-specific Pax6 cKO cerebral organoids is important in this endeavour. This 
conditional mutant model employs the Cre-Lox recombinase system, which can be 
readily established by deriving ES cells from the established cortex-specific Pax6 
cKO mice (Mi et al., 2013). Phenotypes of this Pax6 cKO mouse are well established, 
allowing comparison with the newly established Pax6 cKO cerebral organoids. 
 
The cortex-specific Pax6 cKO mice were maintained on a CD1 background, a stock 
with unknown status of efficiency to derive ES cells (Czechanski et al., 2014). 
Derivation of ES cells was previously inefficient and limited to very few mouse 




following the discovery of ground-state pluripotency, ES cells can be derived from 
any type of mouse background with 60-90% efficiency, a dramatic increase from the 
traditional technique using LIF/serum medium at only 30% efficiency (Czechanski et 
al., 2014; Nichols and Ying, 2006). 
 
Using the “ground state” condition, we found that ES cells can be derived from CD1 
mice with 62% efficiency (n=21). Although this condition has greatly facilitated ES 
cell derivation, prolonged culture in 2i/LIF has been reported to alter the epigenome 
and introduce aneuploidy (Chen et al., 2015; Choi et al., 2017). This could be due to 
the nature of ground state pluripotency, which is a transient stage in vivo; and 
prolonged culture might perturb this equilibrium (Choi et al., 2017; Weinberger et al., 
2016). To prevent these complications, the ES cells were successfully maintained in 
the standard ES medium (LIF/serum) after gradual transition from the 2i/LIF medium. 
 
4.3.2 Characteristics of Pax6 cKO ES cell lines 
 
Although both 2i/LIF and LIF/serum media are able to maintain ES cells in a 
pluripotent state, they support ES cells of distinct embryonic stages. Based on 
transcriptomic data, ES cells cultured in 2i/LIF were found to be comparable to the 
early stage blastocyst, whereas ES cells cultured in LIF/serum condition are reported 
to be equivalent to the late stage blastocyst (E4.5, Martin Gonzalez et al., 2016). 
Furthermore, the differences between these two types of ES cells are reflected in 
many other aspects, including their morphology, heterogeneity and the ability to form 
chimeras (Wu and Izpisua Belmonte, 2015). Indeed, we observed striking changes in 




fairly homogenous and refractile ES cell colonies in 2i/LIF medium, to a more 
heterogenous population of cells in the LIF/serum medium. Recognising the different 
states of ES cells is important, as their characteristics may affect downstream 
applications. For example, due to the difference in the developmental stage of the 
starting cell population, specific types of differentiated cells may appear at later time-
points using 2i ES cells compared to LIF/serum ES cells. 
 
Nevertheless, all four Pax6 cKO ES cell lines cultured in LIF/serum show pluripotent 
characteristics, based on the expression of Oct4 and Nanog (Figure 4.7). Moreover, 
they demonstrated the signature profile of pluripotency, which is heterogenous 
expression of Nanog, with subpopulations of Nanog-high and Nanog-low cells 
(Kalmar et al., 2009). A previous study using quantitative analysis showed a high 
correlation between heterogeneity of Nanog with Oct4, which further categorises ES 
cells into three subpopulations: pluripotent, lineage-primed or differentiated cells 
(Descalzo et al., 2012). For instance, uniform and high levels of both Oct4 and Nanog 
indicate cells with stable pluripotency, a low level of both Nanog and Oct4 indicates 
cells that are primed for differentiation and the absence of both Oct4 and Nanog 
suggest the presence of differentiated cells (Torres-Padilla and Chambers, 2014). 
Although these genes were not analysed quantitatively in this study, heterogenous 
expression of Nanog indicates the heterogeneity of the ES cell lines at the molecular 






4.3.3 Pax6 cKO ES cell lines require MEK/Erk inhibitor for optimum cell 
aggregation  
 
Although heterogeneity is inevitable in serum-containing medium, undifferentiated 
cells should be predominant in a healthy culture, as a higher proportion of 
differentiated cells in ES cell culture could affect the generation of cerebral organoids 
(Lancaster and Knoblich, 2014; Eiraku and Sasai, 2012). Despite careful handling of 
the ES cells, generation of cerebral organoids from the established Pax6 cKO ES cell 
lines revealed inefficient cell aggregation, as the majority of the cells failed to 
aggregate properly. This stage is important, as the number of aggregating cells may 
affect later stage of organoid development, such as in neural induction or cell 
specification (Eiraku and Sasai, 2012). 
 
Interestingly, there is evidence that ES cells derived from recalcitrant strains are 
dependent on exogenous factors such as PD0325901 (MEK/Erk inhibitor) to maintain 
their undifferentiated state (Hanna et al., 2009). Indeed, we show that maintaining the 
established ES cell lines in LIF/serum supplemented with PD0325901 has 
dramatically improved cell aggregation. Interestingly, these cell lines also appeared to 
be dependent on this small molecule, as withdrawal of PD0325901 resulted in 
persistent cell aggregation inefficiency. PD0325901 is one of the small molecules in 
2i culture that inhibits cell differentiation by blocking the MEK/Erk pathway. Its 
combination with serum is sufficient to reduce spontaneous differentiation, thus it is 
routinely used to rescue undifferentiated cells in a very heterogenous ES cell culture 
(Tamm et al., 2013; Ying et al., 2008). Therefore, supplementation of PD0325901 in 





Although a reduced concentration of PD0325901 is safe for ES cell culture (Di 
Stefano et al., 2018), it is not required in standard ES medium, as supplementation 
with Leukaemia inhibitory factor (LIF) is sufficient to maintain the undifferentiated 
cells. Therefore, the requirement of PD0325901 to maintain ES cell culture suggests 
that the signaling pathway to maintain the undifferentiated state in these ES cell lines 
might be different and intrinsic to the recalcitrant strain. Moreover, since ES from 
recalcitrant strains can only be derived using the 2i medium but not the standard 
LIF/serum medium, it is plausible that these small molecules are indeed essential in 
maintaining ES cells, which distinguish them from the permissive strain. 
 
4.3.4 Pax6 cKO ES cells form cerebral organoids with NE structures 
  
We showed that all of the established Pax6 cKO ES cell lines successfully aggregate 
on day one of 3D culture. However, despite the standard condition used, only three of 
them form NE structures, whilst the cKOhet2 line cannot. This is despite comparable 
characteristics of the cKOhet2 ES cells to other cell lines, in terms of expression of 
pluripotency markers and normal karyotype (Figure 4.3, 4.4). 
 
Formation of NE structures is driven by a spontaneous phenomenon known as self-
organisation, governed by segregation of cells and cell fate specification (Lancaster 
and Knoblich, 2014). Although cKOhet2 cells are able to form aggregates, it appears 
that the cells were unable to sort properly and self-organise. The inability to sort out 




al., 1990; Fujimori et al., 1990). To confirm this, it will be important to characterise 
the expression of N-cadherin in cKOhet2 cerebral organoids in future studies.  
 
Furthermore, compared to the other three lines of cerebral organoids, cKOhet2 
cerebral organoids were unable to differentiate into neural progenitors (Pax6+) and 
neurons (Tuj1+). This indicates that the cKOhet2 cell line failed to achieve neural 
specification, despite its pluripotent characteristics (Figure 4.7). Although expression 
of pluripotency markers is the standard test to demonstrate pluripotency, an 
alternative and more stringent pluripotency test via formation of chimeras might be 
necessary to assess whether cKOhet2 cells can truly give rise to cells of the three 
germ layers (Martin Gonzalez et al., 2016; Morgani et al., 2017). Therefore, due to 
the inability of these cells to give rise to neural progenitors and neurons, a functional 
pluripotency assay such as formation of chimera will be useful in future studies to 
validate the pluripotency of cKOhet2 cell line.  
 
Consistent with the aim of this study, this chapter demonstrates efficient derivation of 
ES cells from cortex-specific Pax6 cKO mice. Although most of the isolated 
blastocysts were able to propagate in culture (62%), the odds of obtaining at least four 
karyotypically stable ES cell lines with the correct genotype was only 1/5, which 
requires more than 20 blastocysts to be isolated. No doubt, expertise in handling the 
blastocysts is therefore critical and this process was performed by a lab technician 
(Michael Molinek). However, if this is not available, developing the necessary 
technical skills could take some time. In addition, maintaining 20 ES cell lines 





As described above, ES cells derived from CD1 mice appeared to be dependent on 
inhibition of the MEK/Erk pathway. Nevertheless, they were still able to form 
cerebral organoids in 3D culture, which will assist us to test specific roles of Pax6 in 

















CHAPTER 5: Effects of cortex-specific, acute Pax6 deletion on 




In chapter four, we established embryonic stem cell (ES) lines from Pax6 conditional 
knock out (cKO) mice, which are able to form cerebral organoids in 3D culture. 
These ES lines enable us to probe the cerebral organoid system by acutely removing 
Pax6 specifically in the cortex-specific region. Therefore, specific roles of Pax6 in the 
cortical region of cerebral organoids could be accurately determined, circumventing 
limitations of the constitutive loss of Pax6. 
 
The aim of this chapter is to determine whether Pax6 plays a role in cortical cell 
proliferation following its acute loss in cerebral organoids. Although we have 
previously demonstrated that constitutive loss of Pax6 altered the LI of cerebral 
organoids, it appeared that the alteration was in contrast to what was observed in vivo 
(Mi et al., 2013; Warren et al., 1999). This further suggests the cell cycle regulation 
underlying Pax6 control between these two systems might be different.  
 
In vivo, Pax6 plays a repressive effect on the total cell cycle time (Tc) of cortical 
progenitors – therefore, in the absence of Pax6, the cell cycle is faster, which results 
in a shorter Tc, as well as G1 phase (Mi et al., 2018; Mi et al., 2013). To induce Pax6 
deletion in the organoid system, firstly we demonstrate optimisation of 4-OHT, a 




the system. We then further characterised the activated Cre, showing that it is specific 
to the region expressing the cortex-specific marker, Emx1, and that Pax6 is efficiently 
deleted. Finally, we compared the cell cycle kinetics of Pax6 cKO cerebral organoids 
to the established cell cycle kinetics of Pax6 cKO mice. 
 
Cell cycle parameters such as the Tc and the length of S-phase (Ts) can be calculated 
by several techniques, mainly by tracing cells undergoing S-phase (Nowakowski et 
al., 1989; Martynoga et al., 2005). During S-phase, cells undergo DNA synthesis to 
prepare for the next phase of the cell cycle and this process can be traced by using 
thymidine analogues, such as EdU or BrdU. BrdU cumulative labelling is a classic, 
well-established technique to calculate Ts and Tc, in which the cells were pulsed with 
BrdU periodically until all of the proliferating cells were labelled (Nowakowski et al., 
1989).  
 
This technique is based on several assumptions, including that all of the cells are 
proliferating, and that they are proliferating at the same rate. However, in the case that 
not all of the cells are proliferating, the calculation takes into account the proportion 
of proliferating cells, or the growth fraction (GF). It is also assumed that there is a 
linear relationship in the type of daughter cells produced, or a steady-state growth (i.e 
asymmetric differentiation, with half of the daughter cells continuing to proliferate 
and the other half differentiating). Therefore, a linear regression line can be drawn on 
the data plot and the GF can be determined (Figure 5.1). Equally, the slope of the 








Figure 5.1 Example of graph plotted using data obtained from BrdU 
cumulative labelling. Calculation of Ts and Tc can be determined from the 
information obtained from the graph: GF, Tc-Ts, slope and the y-intercept 













The proportion of cells in S-phase can be determined from the y-intercept of the plot, 
as it is the proportion of cells taking up the first pulse of BrdU (Ts/Tc). Thus, 
information obtained from the graph (GF, GF/Tc, y-intercept and Ts/Tc) can be used 
to calculate the Tc and Ts. 
 
To date, there are no published findings on cell cycle parameters for cerebral 
organoids derived from mouse ES cells. Therefore, exploration of these parameters is 
significant, as a first step to recognise the extent to which the cerebral organoid 






























5.2.1 Optimisation of 4-OHT treatment 
 
To test the efficiency of CreERT2 activation in Pax6 cKO cerebral organoids, two 
different concentrations of 4-OHT (1 µM and 2 µM) across three time points (24, 48, 
72 hours) were compared. In this experiment, two ES cell lines were selected as 
representatives of each genotype, namely cKOhom1 and cKOhet1 lines. Organoids 
were collected at day eight and immunolabelled with GFP, which reports on CreERT2 
(Figure 4.1), and the percentage of NE area expressing CreERT2 (GFP) was then 
quantified using ImageJ. 
 
Quantitative analysis showed that there was a decrease in the proportion of NE area 
expressing GFP upon prolonged treatment of 4-OHT (Figure 5.2A). Treatment with 1 
µM 4-OHT showed that the GFP+ area was ~30% after 24 hours, followed by a slight 
decrease at 48 hours, which further decreased to 25% at 72 hours. A similar trend was 
observed with the 2 µM 4-OHT treatment, as GFP+ area was 31% at 24 hours, and 
further decreased to ~25% at 48 hour. No data was taken at 72 hours as the NE tissues 















Figure 5.2 Comparison between 1 μM and 2 μM 4-OHT treatment at 24, 
48, and 72 hours, on the activation of Cre (GFP) in cerebral organoids. 
(A) Quantitative analysis of GFP+ NE area of cKOhom1 cerebral organoids 
shows no significant difference between 1 μM and 2 μM 4-OHT treatment, 
with 24 hours of treatment sufficient to activate Cre. Data presented as means 
 SEM. (B) Representative images of cKOhom1 cerebral organoids in the 
three different 4-OHT treatments, with 2 μM 4-OHT for 72 hours show 




















Although there was no significant difference between these conditions (ANOVA, 
p>0.05, n.s), it is evident that prolonged 4-OHT treatment did not significantly 
increase Cre activation, with some indication of 4-OHT toxicity at a higher dose (2 
µM). Therefore, 1 µM 4-OHT for 24 hours was used in subsequent experiments. 
 
Interestingly, despite the presence of a Cre reporter allele (Figure 4.5) and the 
expression of Emx1 in both sets of cerebral organoids, activation of Cre can only be 





















Figure 5.3 Activation of Cre (GFP+) in cKOhom1 and cKOhet1 cerebral 
organoids. (A) Representative image of cKOhom1 organoids (Pax6fl/fl) 
showing the presence of GFP+ cells and (B) cKOhet1 organoids (Pax6+/fl) 
















5.2.2 Effect of 4-OHT on cell proliferation in Pax6 cKO organoids 
 
To ensure that the observed effects were due to acute loss of Pax6, and not due to 
other factors such as 4-OHT, the percentage of proliferating cells (Ki67+) in cerebral 

























Figure 5.4 Percentage of proliferating cells in the cKOhom1 (Pax6fl/fl) 
cerebral organoids. (A) Organoids with or without 4-OHT treatment show no 
significant difference in the percentage of proliferating cells (Ki67+). Data are 
meanSEM of organoids from four independent experiments (p<0.05, 
unpaired t-test, not significant). (B) Representative image of organoids with 








Quantitative analysis of Ki67+ cells showed that only 65% of cells in the NE of 
untreated organoids were proliferating (Figure 5.4A), which is 25% lower than the 
number of proliferating cells in the E12.5 embryonic cortex (Caviness et al., 1995; 
Estivill-Torrus et al., 2002). Interestingly, a similar percentage of proliferating cells 
was also found in human cerebral organoids (60%), suggesting a consistent 
percentage of proliferating cells in the organoid systems regardless of the species 
difference (Matsui et al., 2017). Therefore, the lower percentage of proliferating cells 
in the organoids may be due to a difference between the 3D in vitro and in vivo 
systems.  
 
Nevertheless, proliferating cells in the 4-OHT-treated cerebral organoids were 
comparable to the untreated ones (control), indicating that no significant effect was 
observed in cerebral organoids treated with 1 µM 4-OHT for 24 hours (unpaired t-test, 
p>0.05, n.s). Taken together, this condition is suitable in the activation of Cre (Figure 
5.2A) with no concomitant toxicity to the proliferating cells.  
 
5.2.3 Characterisation of CreERT2 expressing (GFP+) cells  
	
Following successful activation of CreERT2 as reported by GFP, the GFP+ cells of 
cKOhom1 and cKOhom2 cerebral organoids were further characterised. Both of these 
organoids are of Pax6fl/fl; Emx1-CreERT2; RCE genotype and were treated with 1 µM 
4-OHT for 24 hours, and collected at day eight.   
 
Consistent with previous observations, GFP immunolabelling showed cells expressing 




in the GFP+ NE further demonstrated a low proportion of GFP+ cells in the NE 
(Figure 5.5A), thus further supporting the observed Cre mosaicism. Cre mosaicism 
resulted in two subpopulations of cells in the NE, the majority of which were GFP- 








Figure 5.5 Quantitative analysis of GFP+ cells in cKOhom1 and 
cKOhom2 cerebral organoids. (A) NE of cKOhom1 and cKOhom2 
organoids show comparable percentage of GFP+ cells. (B) Representative 




As CreERT2 is driven by the Emx1 promoter, it is possible that Cre mosaicism was 
due to mosaic expression of Emx1. To confirm this and to validate whether these Cre-
expressing cells (GFP+) accurately reflect the endogenous expression of Emx1, 4-
OHT-treated cerebral organoids were double-labelled with Emx1 in situ and GFP 
antibody. Quantitative analysis of the GFP+ cells of cKOhom1 showed 92% of these 
cells co-localised with Emx1 (n=3 batches), suggesting the expression of GFP 
reflected the expression of endogenous Emx1 (Figure 5.6A,B). However, due to the 
mosaic pattern of GFP+ cells, there were Emx1-expressing cells without the 
expression of GFP (arrowhead, Figure 5.6A’’, B’’). Therefore, Emx1+ NE consists of 

















Figure 5.6 Expression of Emx1 and GFP (Cre) in cKOhom1 and 
cKOhom2 cerebral organoids. (A, B) Representative images of cKOhom1 
and cKOhom2 organoids labelled with Emx1 and GFP show co-localisation 
between these two markers. (A’’, B’’) However, due to the mosaic expression 
of GFP, there are Emx1+ cells that do not activate Cre (GFP-, arrowhead). 




Having established co-localisation between the expression of GFP and Emx1, we then 
determined whether the Cre-expressing cells (GFP+) successfully deleted Pax6 by 
performing double labelling with GFP and Pax6 antibodies. Indeed, these two 
markers appeared to be exclusively expressed (arrowhead, Figure 5.7A-D). 
Quantitative analysis of cKOhom1 organoids confirmed that 98% of the GFP+ cells 
did not express Pax6, which suggests successful and efficient deletion of Pax6 in the 
























Figure 5.7 Deletion of Pax6 in Cre-expressing cells (GFP+). (A, B) 
Representative images of cKOhom1 (C, D) and cKOhom2 organoids labelled 
with GFP and Pax6 show exclusive expression of these two markers 







Taken together, 4-OHT-treated Pax6 cKO organoids resulted in two populations of 
cells in Emx1+ NE, with successful deletion of Pax6 in the GFP+ cells. This allows 
comparison between GFP+ and GFP- cells in subsequent experiments.  
 
5.2.4 Acute Pax6 deletion does not alter the labelling index  
 
To determine the effect of acute cortex-specific Pax6 deletion on cortical progenitor 
proliferation of cerebral organoids, the proportion of cells in S-phase (EdU+) or 
labelling index (LI) of EdU+ cells of GFP+ and GFP- cells (control) in cKOhom1 and 
cKOhom2 organoids were examined. Quantitative analysis showed a non-significant 









Figure 5.8 Labelling index (LI) of GFP+ and GFP- cells of both cKOhom1 
and cKOhom2 cerebral organoids. (A) GFP+ cells showed a non-significant 
decrease in LI compared to control (GFP-) cell. Means are presented as SEM 
(p>0.05, t-test, n.s). (B). Representative images of cKOhom1 and cKOhom2 




Although the difference was not significant (t-test, p>0.05, n.s), the decreased LI was 
consistent with the LI observed in Pax6-/- cerebral organoids (chapter three). The 
subtle difference found in the Pax6 cKO organoids might be due to the presence of 
control cells (GFP-) next to the mutant cells (GFP+) – which might influence cell 
proliferation of the mutant cells. 
 
Nevertheless, both constitutive and acute loss of Pax6 in cerebral organoids resulted 
in a decreased LI, in contrast to the increased LI of both Pax6-/- and Pax6 cKO mutant 
embryos (Mi et al., 2013; Warren et al., 1999). LI analysis estimates the proportion of 
cells in S-phase, without information on the cell cycle kinetics such as the cell cycle 
length. Therefore, to address whether this discrepancy is due to changes in the cell 
cycle kinetics, we then determined the total cell cycle time (Tc) and the length of S 
phase (Ts) of the GFP+ and GFP- cells. 
 
5.2.5 Acute Pax6 deletion does not alter cell cycle length  
	
To calculate cell cycle time (Tc), cumulative EdU labelling was performed on both 
cKOhom1 and cKOhom2 cerebral organoids every two hours in a total of five time 










Figure 5.9 Representative images of cerebral organoids taken every two 







The organoids were collected at day 8, labelled with GFP and EdU and the proportion 
of EdU+ cells of both GFP+ and GFP- cells was calculated (Appendix B) and plotted 






























Figure 5.10 Graph of the cumulative EdU labelling in cKOhom1 and 
cKOhom2 cerebral organoids.  Proportions of EdU+ cells in both GFP+ and 
GFP- cells increased over time and data were presented as meansSEM 
(n=6). Cell cycle parameters were extrapolated from the trendline and 
equation obtained from the least square fit analysis; y=	 0.0147x + 0.1634 










The graph plotted follows the protocol described in (Nowakowski et al., 1989), which 
allows determination of the proportion of proliferating cells or growth fraction (GF), 
the total cell cycle time (Tc) and the length of S phase (Ts). Calculation of the Tc and 
Ts of GFP+, GFP-, as well as the established Tc and Ts of E12.5 cortical progenitors 
(Takahashi et al.,1995; Estivill-Torrus et al., 2002) is summarised in Table 5.2.1.   
 
Table 5.2.1 Calculation of cell cycle kinetics of GFP+ and GFP- cells 
 GFP- (control) GFP+ (Pax6fl/fl) E12.5 cortex (wt) 
GF 0.43 0.3 1.0 
Tc (hour) 19 20 12 
Ts (hour) 9 11 4.5 
 
Interestingly, the GF of GFP- cells was lower than the GF of E12.5 cortical 
progenitors, which suggests that cerebral organoids have a lower proportion of 
proliferating cells compared to embryonic cortex.  
 
On the other hand, GFP+ cells showed lower GF than the control (GFP- cells), 
suggesting a decrease in proliferating cells following acute Pax6 deletion. In addition, 
the Tc of GFP+ cells was slightly longer by 10% than the Tc of control cells (t-test, 
p>0.05, n.s). This subtle effect might be due to the presence of both cell populations 
(GFP+ and GFP- cells) next to each other. Therefore, effects from the loss of Pax6 in 
GFP+ cells might be compensated by the external cues from the control cells (GFP-), 





Although acute cortex-specific Pax6 deletion in the organoids does not alter the cell 
cycle length, this phenotype is similar to the findings of Mi Da et al., 2013, which 
showed no significant changes in the Tc of regions expressing low levels of Pax6 
(caudo-medially), following acute Pax6 deletion. However, due to the heterogenous 
expression of Pax6 in the untreated organoids, it is not possible to determine whether 
the GFP+ cells were also expressing low levels of Pax6 prior to treatment with 4-
OHT (Figure 5.2). Furthermore, it was difficult to determine the regional identity of 
the organoids, due to the lack of developmental axes.  
 
In addition, there was also no significant change in the length of S-phase between 
GFP+ and GFP- cell populations. Therefore, acute deletion of Pax6 does not alter the 
cell cycle length of cortical progenitors in cerebral organoids. As Pax6 control is very 

























Results presented in this chapter provided insights into the effects of acute Pax6 
deletion in cerebral organoids, particularly into the effects on cell cycle kinetics.  
 
5.3.1 Optimum conditions for CreERT2 activation in cerebral organoids  
 
Our Pax6cKO cerebral organoids has enabled spatio-temporal control of Pax6 
deletion, which circumvents the limitations of constitutive loss of Pax6 – thus the 
roles of Pax6 can be more accurately determined (Georgala et al., 2011; Mi et al., 
2018). This control requires optimisation of 4-OHT treatment, in order to induce 
CreERT2 activation, as well as Pax6 deletion. This inducible system has been 
successfully used in mouse, with efficient activation of CreERT2 after 48 hours, 
followed by loss of detectable Pax6 protein after 72 hours (Mi et al., 2013). 
 
We found that CreERT2 activation in cerebral organoids occurs at a relatively faster 
rate, which is 24 hours earlier than CreERT2 activation in vivo (Figure 5.2). This is 
consistent with the activation of Cre another in vitro study that used the same system 
in ES cells (Vallier et al., 2001). This rapid activation is due to the use of 4-OHT, a 
tamoxifen metabolite; which eliminates the intermediate stage of tamoxifen 
conversion to 4-OHT, that caused the lag in CreERT2 activation in vivo (Felker et al., 
2016).  
 
Furthermore, prolonged treatment with 4-OHT appears to have no significant effect 




suggesting the direct action of 4-OHT in vitro at 24 hours, which further supports 
rapid activation of CreERT2. This direct and rapid effect in vitro may be due to the 
instability of 4-OHT, as its potency is reduced in prolonged cell culture (after 48 
hours) due to isomerisation into cis-4-OHT, an isoform with lower affinity to CreERT2 
(Katzenellenbogen et al., 1984). 
 
Although activation of Cre with 1uM 4-OHT is comparable to 2 µM, without 
concomitant toxicity, we found that 2 µM 4-OHT at 72 hours was detrimental to the 
organoids, evident from the damaged organoid tissue in this condition (Figure 5.2B). 
This could be due to 4-OHT toxicity leading to a high level of Cre expression, which 
has been shown to induce apoptosis, DNA damage and aneuploidy (Gauduchon et al., 
2005; Loonstra et al., 2001; Schmidt-Supprian and Rajewsky, 2007). Therefore, it 
may also be informative in future studies to determine possible toxicity effects of 4-
OHT by determining the percentage of apoptosis in the organoids. 
 
The safe use of 1 µM 4-OHT is further supported by the comparable percentage of 
proliferating cells between organoids treated with 1 µM 4-OHT and untreated 
organoids (Figure 5.4). Interestingly, it appears that there are fewer proliferating cells 
in (untreated) cerebral organoids (60%) than in the embryonic cortex (90-100%). Our 
finding is also consistent with the percentage of proliferating cells reported in human 
cerebral organoids, despite the species difference (Matsui et al., 2017). Considering 
the simple set up of the in vitro system, it is possible that the reduced proliferating 
cells in cerebral organoids could be due to the use of minimal medium that may lack 
the required factors pertinent to cell proliferation. For example, cerebrospinal fluid 




cortex (Lehtinen et al., 2011). This fluid is rich with signalling molecules that play 
significant roles in the proliferation and survival of cortical progenitors, which may be 
absent in the minimal medium used in vitro.  
 
5.3.2 CreERT2 activation in cerebral organoids is mosaic  
 
One of the caveats of Cre-Loxp technology observed in this study is Cre mosaicism, 
which is evident from the low proportion of Cre-expressing cells (GFP+) in the 
organoids NE, in a sporadic fashion (Figure 5.6). Furthermore, although these GFP+ 
cells reflected the endogenous expression of Emx1, Emx1/GFP double labelling 
showed that there were Emx1+ cells without co-expression with GFP (Figure 5.6 A’’, 
B’’).  
 
Cre mosaicism suggests that Cre activation may be incomplete, due to its inconsistent 
and variable activity between tissues in a single litter (Eckardt et al., 2004; Heffner et 
al., 2012). In the context of a 3D in vitro culture, it is possible that the inconsistent 
Cre expression may be due to the influence of mass transfer diffusion. Established 
studies have shown that the concentrations of oxygen and cytokines are lower at the 
core centre of 3D in vitro structures, which subsequently influences the niche and 
differentiation efficiency, resulting in heterogeneity (Van Winkle et al., 2012). Thus, 
the 3D structure of organoids and their lack of vasculature could result in 
heterogenous uptake of 4-OHT, as the diffusion of 4-OHT at the surface may differ 
from the centre of organoids, forming a concentration gradient within the 3D 
structure. Agitation has been shown to improve mass transfer within the 3D in vitro 




uptake of 4-OHT in the organoids, which may impact the expression of Cre 
(Carpenedo et al., 2007). 
 
Inconsistent Cre activity is also evident between littermates (Heffner et al., 2012), 
which might explain the undetected Cre activity in the cKOhet1 organoids (Figure 
5.3). cKOhet1 is a littermate to cKOhom1, as they were derived from the same dam in 
batch 115 (table 4.1). Although there is another cell line with Pax6+/fl genotype from 
batch 115 (Figure 4.5B), the cell line does not express Cre, thus hampers its utility.  
 
In another note, a study has shown that genomic PCR is able to detect inactivated Cre, 
which could be a consequence of multiple recombination events after consecutive 
generations (Schulz et al., 2007). Therefore, it is plausible that the undetectable 
activation of Cre in cKOhet1 organoids could be due to a false positive genotype, 
detected by genomic PCR (Figure 4.5). It would therefore be necessary in future 
studies to re-assess the result by checking the Cre mRNA transcripts by RT-PCR. 
 
Nevertheless, this confounding result would complicate subsequent experiments. 
Therefore, an alternative method is to take advantage of the Cre mosaicism and use 
the neighbouring Cre negative cells (GFP-) in the NE as an isogenic control.  
 
5.3.3 Effect of acute Pax6 deletion on cortical progenitor proliferation 
 
One of the important roles of Pax6 in cortical development is in cell proliferation, 
demonstrated by the altered labelling index (LI) in both Pax6-/- and Pax6 cKO mouse 




synthesising cells through incorporation of a thymidine analogue such as EdU, 
therefore it is an estimate of cells undergoing S-phase, indicative of proliferative 
activity. 
 
Here we present the effect of acute, cortex-specific Pax6 deletion on the organoids’ 
cortical proliferation. We showed that cortex-specific Pax6 deletion resulted in a 
decreased LI compared to control (Figure 5.8), consistent with the effect seen in the 
LI of Pax6-/- cerebral organoids (chapter three). However, despite the consistent trend 
in both constitutive and conditional Pax6 mutant cerebral organoids, it is important to 
note that the decreased LI in the latter is not significant. This subtle effect might be 
due to the observed Cre-mosaicism, as the mutant cells (GFP+) are surrounded by 
control cells (GFP-), which may influence cell proliferation. 
 
This consequently may indicate a non-autonomous (indirect) requirement of Pax6 in 
cortical proliferation of organoids, which is important in distinguishing between the 
primary and secondary defects of Pax6 (Talamillo et al., 2003). For instance, the cell 
autonomous requirement of Pax6 has been demonstrated in chimera studies, which 
show that Pax6 is required autonomously for several cellular processes, such as 
production of cortical progenitors in the correct number, expression of the basal 
progenitor marker, Tbr2, neuronal migration, and the correct level of Pax6 in cell 
proliferation (Manuel et al., 2006; Quinn et al., 2007; Talamillo et al., 2003). 
Chimeras consist of cells of two different genotypes; for example, normal (Pax6+/+) 
and Pax6-/- mutant cells, which allows the analysis of Pax6-/- cells in a normal niche. 
If the abnormal characteristics of Pax6-/- cells persist despite the normal environment, 




of Pax6-/- cells, this indicates a cell autonomous requirement of Pax6. On the 
contrary, non-significant defects in the mutant cells in the presence of Pax6+/+ cells 
(normal niche) indicates that Pax6 is required non-autonomously in cell proliferation. 
 
Therefore, as there is no significant change in the LI of GFP+ cells, this suggests that 
Pax6 may be cell non-autonomously required in cortical proliferation of organoids, 
and that the proliferation defect is secondary. In addition, the non-altered LI in the 
Pax6 cKO organoids also corresponds to the LI of caudo-medial region of Pax6 cKO 
mice (Mi et al., 2013). It is well established that Pax6 control in cortical proliferation 
is regional, as acute deletion of Pax6 only affects the rostro-lateral region where Pax6 
is highly expressed, whereas there is no significant change in the LI of caudo-medial 
region where Pax6 expression is relatively low (Mi et al., 2013). Therefore, it is 
possible that Pax6 expression in the organoids is relatively low, prior to acute deletion 
of Pax6. Unfortunately, due to the lack of axes and heterogenous nature of the 
organoids, this would be difficult to demonstrate. 
 
Another possible explanation underlying the abnormal LI would be a difference in 









5.3.4 Cortical progenitors of cerebral organoids cycle longer with 
comparable S-phase length to embryonic cerebral cortex 
 
Despite rapid developments in the field of organoids, little is known about their cell 
cycle kinetics. Cell cycle regulation is fundamental to tissue morphogenesis, and any 
errors in the kinetics could lead to abnormalities and diseases such as, cancer 
(Cecchini et al., 2012).  
 
Due to the established role of Pax6’s in cell proliferation, it is plausible that cell cycle 
kinetics can account for the differences observed between organoids and their 
matched in vivo counterparts. For example, we know there is an altered LI in 
constitutive and conditional Pax6 mutant cortical progenitors, which indicates a 
change in the proportion of cells in S-phase. However, there is insufficient 
information to address why or how this change occurs.  
 
In vivo findings have confirmed that the altered LI following acute loss of Pax6 is due 
to a decrease in cell cycle time (Tc) as well as in G1 phase, which results in rapid cell 
proliferation (Mi et al., 2018; Mi et al., 2013). However, it is important to note that 
Pax6 exerts its effect in a regional fashion, and this change is specific to the rostro-
lateral region, where Pax6 is highly expressed, but not in caudo-medial region, where 
Pax6 expression is low (Mi et al., 2013). Therefore, as there is no significant change 
in the LI of GFP+ cells in Pax6 cKO cerebral organoids, which is similar to the acute 






Cumulative EdU labelling was used to calculate the total cell cycle time (Tc) and the 
length of S-phase (Ts) of both Pax6 mutant (GFP+) and control cells (GFP-). 
Interestingly, the control cells (GFP-) show longer Tc (19h) than the matched E12.5 
Pax6 cKO mice control cells (12h), which suggests that cortical progenitors in 
organoids cycle at a slower rate than in vivo. As the length of S-phase between these 
two types of control cells are remarkably similar (i.e. 4h in GFP- cells and 4.5h in 
Pax6 cKO control cells), the lengthening of Tc in cerebral organoids could be due to 
the lengthening of other cell cycle parameters, such as G1 phase. 
 
It is well established that G1 phase is associated with cell fate decisions and 
differentiation (Julian et al., 2016). Studies using pluripotent stem cells show that 
these cells have characteristically truncated G1 and G2 phases, suggesting that they 
proliferate rapidly. However, as they differentiate into other types of cells, G1 and G2 
phase become longer and recent studies have shown that the expression of 
developmental genes is highest/most concentrated at G1 phase, suggesting that stem 
cells are more susceptible to signals promoting differentiation/commitment in this 
phase (Singh et al., 2013). This is consistent with the studies in cerebral cortical cells, 
which consist of two types of progenitors with distinct length of G1 phase. The apical 
progenitors are the primary progenitors that maintain the progenitor pool by 
symmetrical division, as well as giving rise to the secondary progenitor pool (basal 
progenitors) by asymmetrical division. On the other hand, basal progenitors have a 
relatively longer G1 phase and mainly give rise into neuronal cells (Calegari et al., 
2005). Therefore G1 is a critical window for the balance between cell 





Given that the proportion of non-proliferating cells in the organoids is higher than in 
the embryonic cortex (Figure 5.4), it is possible that most of cortical progenitors in 
organoids undergo neurogenic divisions, therefore spending more time in G1 phase, 
slowing down the proliferation rate. It would therefore be interesting to further 
confirm this by characterising the G1 phase of the cells, as well as comparing the 
proportion of apical progenitors (Pax6+) and basal progenitors (Tbr2+). 
 
5.3.5 Pax6 does not regulate cell cycle length of cortical progenitors in 
cerebral organoids 
 
Interestingly, we found that Pax6 mutant cells (GFP+) have slightly longer Tc than 
control (GFP-) cells, though the change is not significant (Figure 5.10). This suggests 
that cell cycle kinetics in the cerebral organoids are not regulated by Pax6, and this is 
consistent with our previous finding, which demonstrated no significant change in the 
LI of GFP+ cells (Figure 5.8).  
 
Given the regional effect of Pax6 in early corticogenesis, this finding is consistent 
with the acute loss of Pax6 in the caudo-medial region of the cortex (low expression 
of Pax6), which also shows no significant difference in the Tc (Mi et al., 2013). 
Therefore, it is possible that cerebral organoids have relatively low Pax6 expression, 
which may be insufficient to repress Cdk6, a cell cycle regulator that is directly 
regulated by Pax6 in the rostro-lateral region (Mi et al., 2018). However, due to the 
lack of developmental axes and inherent heterogeneity of the organoids, this would be 
difficult to address, which highlights some of the shortcomings of this complex and 




One of the caveats of the mosaic analysis in this study is that Pax6 expression in the 
GFP- cells (control) is also mosaic, resulting in the presence of GFP-Pax6- cells in the 
cortical, Emx1-expressing NE (Figure 5.7). Thus the estimation of cell cycle length in 
the organoids may be overestimated due to the inclusion of Pax6- cells as part of the 
control.  
 
In addition, a recent finding discovered opposite roles for Pax6 in the cell cycle of 
telencephalic and diencephalic progenitors (Quintana-Urzainqui et al., 2018). Acute 
deletion of Pax6 in the thalamus showed a decreased LI in the Pax6- progenitors, with 
a corresponding decrease in Tc, compared to control. The contrasting role of Pax6 
between telencephalic and diencephalic tissues is due to the presence of Foxg1, a 
transcription factor expressed in telencephalic progenitors but not in the diencephalic 
progenitors.  Therefore, it would be interesting to examine the expression of Foxg1 in 
these organoids in future studies. 
 
Essentially, our findings further highlight the context-specific and dynamic role of 
Pax6 in cell proliferation, which is dependent on its level of expression as well as the 
specific region of expression. Given this complexity, it is possible that Pax6 control in 
cerebral organoids cell proliferation is highly dependent on the types of tissues that 
exist in this 3D in vitro model, which is heterogenous and requires more detailed 
characterisation than we previously anticipated.  
 
Taken together, we provide a comparison of the cell cycle kinetics between cerebral 
organoids and their matched in vivo counterpart. We found that organoids have a 




length of S-phase between cerebral organoids and embryonic cortex is remarkably 
similar. Although it is evident that Pax6 controls cell proliferation in both of these 
systems, its role in the cell cycle kinetics of cortical progenitors in organoids seems 
unclear due to the complication and caveats of the analysis, in addition to Pax6 






















CHAPTER 6: DISCUSSION 
 
Previous studies have demonstrated the resemblance of mouse cerebral organoids to 
mouse embryonic cerebral cortex in many aspects, such as cellular composition, 
lamination and organisation (Eiraku et al., 2008; Nasu et al., 2012). Furthermore, 
cerebral organoids can also be established from human pluripotent cells, which allows 
investigation on human cortical-like tissues that would be otherwise difficult to 
access. Indeed, most reported studies use human cerebral organoids, which has been 
extensively optimised and characterised (Lancaster et al., 2017; Renner et al., 2017). 
These studies show that human cerebral organoids follow human-specific cortical 
development, including the presence of outer radial glia (oRG) cells, a type of cortical 
progenitor unique to human (Qian et al., 2016). Furthermore, transcriptomic and 
epigenomic data reported the resemblance of human cerebral organoids to human 
mid-trimester embryonic development (Camp et al., 2015; Luo et al., 2016; Quadrato 
et al., 2017b). 
 
Despite rapid progress in this field, mechanisms underlying cerebral organoid 
development are much less understood. This is important in order to understand the 
accuracy and utility of this 3D in vitro model. To address whether cerebral organoids 
can be used as a tool for studying forebrain development, it is important to ensure that 
the phenotypes of cerebral organoids in a normal and mutant conditions matched with 
the phenotypes of their in vivo counterparts. To test this, mouse cerebral organoids 
provide a good model, as we understand much more of mouse forebrain development, 
in addition to readily available genetically modified (GM) mice. Both of these factors 




phenotypes and subsequently compare them to the matched GM mouse embryonic 
cerebral cortex. Furthermore, engineering and manipulation of the 3D in vitro system 
is more feasible and practical using mouse cerebral organoids, as their developmental 
time is shorter than humans. 
 
Firstly, we established a robust 3D culture protocol, which demonstrates reproducible 
formation of NE structures expressing Foxg1, an early marker of telencephalic tissues 
(Figure 3.1). A robust protocol is essential to produce consistent and reproducible 
results, in order to identify phenotypes in Pax6-/- cerebral organoids. Despite the 
robust formation of NE, characteristics of each organoids are unique. This is due to 
the absence of developmental axes in organoids and their random orientation during 
cryosectioning. Furthermore, organoids appear to be more variable between batches – 
and this is consistent with limitations reported by other studies (Lancaster et al., 2017; 
Renner et al., 2017). This heterogeneity leads to the difficulty to determine specific 
region of interest (ROI). Although heterogeneity is inevitable in organoids culture, 
ROI can be addressed by using specific molecular markers. For example, to 
understand the roles of Pax6 in cortical structures of cerebral organoids in this study, 
analysis and quantification was limited to NE structures within Pax6-/- cerebral 
organoids that expressed cortex-specific markers, such as Tbr2. 
 
We discovered that Pax6-/- cerebral organoids reproduce the main cellular phenotypes 
described in E12.5 Pax6-/- embryonic cortex (Estivill-Torrus et al., 2002; Quinn et al., 
2007; Warren et al., 1999), such as an increase in abventricular mitoses (Figure 3.10), 
altered labelling index (Figure 3.11), and precocious differentiation (Figure 3.12). 




regulatory mechanism, thus making organoids a potential additional tool in studying 
corticogenesis, complementary to mouse models. This finding is significant, as this is 
the first comparative study, to our knowledge, which compares mutant cerebral 
organoids to the matched in vivo model. 
 
However, it is important to note that although Pax6-/- cerebral organoids show 
proliferation defects based on the decreased labelling index (LI) of cells in S-phase, 
this is in contrast to the increased LI found in the Pax6-/- embryonic cerebral cortex 
(Mi et al., 2013; Warren et al., 1999). This discrepancy is addressed in the second part 
of the study, which aimed to assess cell cycle kinetics of cerebral organoids in both 
normal and Pax6 mutant condition. Prior to cell cycle analysis, we demonstrated 
successful establishment of ES cell lines derived from blastocysts of Pax6 conditional 
knock-out (cKO) mice, a conditional mutant model that allows cortex-specific and 
acute Pax6 deletion (Figure 4.7). This mouse model has been used in a recent Pax6 
study, as acute Pax6 deletion in a cortex-specific region eliminates the possibility of 
secondary effects due to constitutive loss of Pax6 (Mi et al., 2013). In addition, the 
presence of a Cre reporter allele facilitates analysis of cerebral organoids, as it is 
driven by Emx1 which illuminates a cortex-specific region (Kessaris et al., 2006). 
 
Our successful establishment of Pax6 cKO ES cells supports the efficiency of the 
chemically-defined medium known as 2i/LIF to derive ES cells from any mouse 
strain, including from CD1 background (Czechanski et al., 2014; Nichols et al., 
2009). We showed that 62% of the derived blastocysts were successfully cultured and 
maintained as ES cells, with just four cell lines are karyotypically normal and carry 




the expression of Oct4 and Nanog, and are able to aggregate in a serum-free medium 
(Figure 4.8, 4.9).  
 
Although these ES cell lines can aggregate in a serum-free medium, we found that the 
aggregation is suboptimal, as only a few of the cells aggregated, which resulted in 
smaller aggregates (Figure 4.9). Studies have shown that the size of aggregates 
eventually influences cell fate, possibly due to differences in cell interactions 
(Valamehr et al., 2008). We later found that the cell aggregation was dramatically 
improved when ES cells are maintained in ES medium supplemented with 
PD0325901, a MEK/Erk inhibitor, prior to differentiation. Although it is well 
established that supplementation with Leukemia inhibitory factor (LIF) is sufficient to 
maintain ES cells in an undifferentiated state, dependence on MEK/Erk inhibition 
seems to suggest additional mechanisms underlying the undifferentiated state in our 
ES cell lines. In fact, our finding is consistent with the work of Hanna et al., 2009, 
who reported similar findings: their pluripotent stem cell lines, which are derived 
from a non-obese diabetic (NOD) mouse strain (non-permissive), are dependent on 
MEK/Erk inhibitor to maintain an undifferentiated state. This may suggest that mouse 
genetic background (permissive/non-permissive strain) plays an important role in ES 
cell pluripotency, which can be regulated by exogenous factors, for example by a 
MEK/Erk inhibitor. In addition, future studies should also determine whether there is 
an increased cell death in the organoids by including apoptosis studies, such as 
TUNEL assay or expression of Caspase. 
 
We then found that although all of the four ES cell lines successfully aggregate, one 




self-organise. Self-organisation stems from the ability of cells to sort themselves, 
based on the presence of cell adhesion molecules (Lancaster and Knoblich, 2014). 
These cell adhesion molecules interact with extracellular matrix (Matrigel) and 
activate downstream effector molecules such as extracellular regulated kinase (Erk), 
which promotes cell motility (Tanimura and Takeda, 2017). Therefore, it is 
conceivable that the inability of cKOhet2 to form NE structures may be due to the 
effect of MEK/Erk inhibition, as there is evidence that Erk promotes cell motility, 
which is part of self-organisation (Klemke et al., 1997). Indeed, recent reports found 
that prolonged treatment with MEK/Erk inhibitor can affect the stability and 
epigenome of ES cells (Choi et al., 2017; Di Stefano et al., 2018). However, as the 
effect appears to be dose-dependent, more recent study demonstrate that lower doses 
of PD0325901 supplementation do not induce epigenomic changes that lead to 
chromosomal abnormality, further supporting the safe conditions used in this study 
(Di Stefano et al., 2018). As each cell line is unique, thus subject to clonal variation, 
this might explain the susceptibility of cKOhet2 to MEK/Erk inhibition, despite the 
standard treatment with PD0325901 to all four ES cell lines. Taken together, only 
three ES cell lines successfully self-organise, forming cerebral organoids (Figure 
4.10). 
 
In chapter five, we demonstrated that Cre activation in cerebral organoids seems to be 
less efficient compared to in vivo. This is based on the activation of Cre, which can 
be observed only in cerebral organoids with homozygous floxed Pax6 alleles 
(cKOhom1 and cKOhom2) upon treatment with 4-OHT, but cKOhet1 did not (Figure 
5.3). Furthermore, Cre activation in both cKOhom1 and cKOhom2 appears to be 




organoid, and between organoid littermates (Heffner et al., 2012). The inefficient Cre 
activation might be due to the 3D structure of cerebral organoids and the absence of 
vascularisation, which may affect the uptake of 4-OHT.  
 
Studies have shown that the growth of 3D in vitro models is hampered by the access 
of nutrients, oxygen and growth factors to their core, resulting in concentration 
gradients and uneven diffusion of these factors to the cells, especially near to the 
centre (Lancaster and Knoblich, 2014; Van Winkle et al., 2012). This may include the 
uptake of 4-OHT, which could diffuse heterogeneously, causing heterogeneous Cre 
activation and mosaic expression. Furthermore, 4-OHT is given intravenously in vivo, 
which could also explain its efficient 4-OHT uptake, in contrast to cerebral organoids, 
which lack vascularisation.  
 
Despite the Cre mosaicism, we found that treatment with 1uM 4-OHT for 24 hours is 
sufficient to activate Cre and remove Pax6 in cerebral organoids (Figure 5.7). 
Although prolonged treatment had no significant effect on Cre activation, 2 µM 4-
OHT treatment for 72 hours was detrimental to the tissues. Therefore, Cre activation 
is more rapid in vitro, with activation evident by 24 hours compared to 48 hours in 
vivo (Figure 5.2). This finding supports the observations of Felker et al., 2016 who 
systematically assessed 4-OHT action in vitro, and found that the trans isoform of this 
molecule (the more potent isoform) is stable for 24 hours in vitro. However, 4-OHT 
undergoes isomerization after 48 hours, forming the cis-isoform, which has lower 
affinity to the estrogen receptor. Therefore, this may justify the rapid action of 4-
OHT, and the insignificant effect of prolonged treatment, in vitro (Figure 5.2A). 




intermediate step that converts tamoxifen to 4-OHT, which cause the lag in Cre 
activation in vivo (Felker et al., 2016). Due to the previously mentioned 
complications of both cKOhet1 and cKOhet2, these two cell lines were not used in the 
subsequent cell cycle analysis.  
 
Cre mosaicism has enabled cells in the cKOhom1 and cKOhom2 organoids to either 
activate Cre (GFP+) in the Emx1+ region, thus acutely removing Pax6 (Pax6-), or 
remain Cre- (GFP-), providing an isogenic control (Figure 5.7). Therefore, taking 
advantage of Cre mosaicism, which generates both experimental (GFP+) and control 
(GFP-) cells, we report cell cycle analysis in both cKOhom1 and cKOhom2 cerebral 
organoids.  
 
First we showed that there is a non-significant decrease in the LI of GFP+ cells 
compared to the control (Figure 5.8), suggesting that there are no proliferation defects 
following acute deletion of Pax6 in the cortical progenitors of cerebral organoids. 
Interestingly, both conditional and constitutive loss of Pax6 in cerebral organoids 
show a consistent trend in the LI, as it decreased compared to the control (Figure 
3.11). This is in contrast to the increased LI of Pax6-/- embryonic cortex, suggesting a 
gap between these two systems.  
 
This gap may be due to the artificial environment of the in vitro system, as cerebral 
organoids were cultured in a minimal medium that only consists of basal medium and 
KSR. The use of minimal medium is based on the principle of neural default model; 
whereby in the absence of external factors, ES cells will acquire a default neural 




Brivanlou, 2007). However, compared to the embryonic cortex, the minimal medium 
may be lacking of many factors important for cortical progenitor proliferation. For 
example, the cerebral cortex is located next to ventricles containing cerebrospinal 
fluid (CSF), which contains extrinsic signaling molecules such as FGF, Shh, IGF-1 
and IGF-2 that may influence cortical cell proliferation (Lehtinen et al., 2011). These 
exogenous factors are transduced to apical progenitors via their primary cilia, which 
are extended and immersed in CSF (Louvi and Grove, 2011; Lun et al., 2015). 
Furthermore, a recent study found that cortical explants and neurosphere cultures 
could be maintained in a primary cerebrospinal fluid (CSF) used as a culture medium, 
without any additional factors (Lehtinen et al., 2011). Indeed, there are growing 
evidence of the importance of CSF in normal cortical development (Lehtinen et al., 
2011; Pothayee et al., 2018; Shen, 2018).  
 
Nevertheless, the subtle, yet non-significant, change in the LI of Pax6 cKO organoids 
might be due to the use of isogenic control (GFP- cells), present among the Pax6-/- 
cell population (GFP+). This could imply that the control cells (Pax6+/+) may have 
influence or rescue the effect of acute loss of Pax6 on cortical progenitor 
proliferation, suggesting that Pax6 has a cell non-autonomous effect in cerebral 
organoids. Therefore, cell proliferation could be a secondary defect in the absence of 
Pax6 in cerebral organoids. This could further explain the discrepancies in the LI data 
between cerebral organoids and E12.5 embryonic cortex, described in chapter three. 
 
Alternatively, the cell cycle kinetics data could also explain the non-significant 
decrease in LI of Pax6 cKO organoids. To date, cell cycle analysis of cerebral 




phase (Matsui et al., 2017), and measuring the proportion of cells exiting the cell 
cycle (Li et al., 2016). Therefore, there is a lack of information on the cell cycle 
kinetics of cerebral organoids, such as the length of the cell cycle (Mason and Price, 
2016). Hence, we report a novel cell cycle kinetics data, which includes the total cell 
cycle time (Tc) and S–phase length (Ts) of cerebral organoids, following acute 
deletion of Pax6.  
 
First we calculated the Tc of the control cortical progenitors (GFP-) as a baseline, and 
compare it to the Tc of matched in vivo counterpart, which is the control Pax6 cKO 
embryonic cortex. Interestingly, the Tc of GFP- cortical progenitors was slightly 
longer than the Tc of control Pax6 cKO embryonic cortex. This is possibly due to the 
lengthening of the G1 phase. Studies have shown that G1 phase is an important 
window for cell fate determination, as cells are susceptible to differentiation signals in 
this period (Dalton, 2015). For example, a truncated G1 phase is characteristic of 
pluripotent stem cells, and as the cells differentiate, the G1 phase lengthens with 
overall lengthening of Tc (Singh et al., 2013). In addition, G1 phase also distinguishes 
the apical and basal progenitors of embryonic cortex, as it is longer in the latter, 
which is associated with their neurogenic cell division (Calegari et al., 2005). 
Therefore, if the G1 phase is longer in the cortical progenitors of organoids, it is also 
plausible that they are undergoing neurogenic division, which would result in more 
post-mitotic neurons. Indeed, the proportion of non-proliferating cells (Ki67-) is 
higher in cerebral organoids than in embryonic cortex, which supports the possibility 
of a longer G1 phase, thus a longer Tc in cerebral organoid cortical progenitors. To 
further confirm this, future studies should characterise these non-proliferating cells 




We then showed that there was no significant change in the Tc of mutant cells (GFP+) 
compared to control cells (GFP-), which supports our previous finding that revealed 
no significant changes in the LI of GFP+ cells. Interestingly, this phenotype is similar 
to the Tc of cortical progenitors in the caudo-medial region of Pax6 cKO embryonic 
cortex, which correlates with low Pax6 expression (Manuel et al., 2015). It is well 
established that Pax6 action is region-specific. For example, acute Pax6 deletion 
accelerates cell proliferation and shortens the Tc of cortical progenitors only in the 
rostro-lateral region, where Pax6 expression is the highest, and no significant effect 
was observed in caudo-medial cortex, where Pax6 expression is relatively low (Mi et 
al. 2013). Therefore, it is conceivable that the level of Pax6 expression in cerebral 
organoids is low, thus no alteration is observed in their Tc upon acute Pax6 deletion. 
However, due to the absence of developmental axes and organoid heterogeneity, it is 
impossible to determine the regions associated with the level of Pax6 expression in 
cerebral organoids prior to acute deletion of Pax6. Furthermore, considering the use 
mosaic analysis in the calculation of cell cycle kinetics, it cannot be ruled out that this 
could also be due to a cell non-autonomous requirement of Pax6 in cerebral 
organoids. 
  
Despite these encouraging results, it is worth noting the limitations encountered in 
this study. Firstly, cerebral organoids is a heterogenous model lacking of 
developmental axes. To address this, it is important to specify the region of interest 
(in this case, cortex) by using a cortex-specific marker such as Tbr2 or Emx1. 
Quantitative analysis is also essential to address batch-to-batch variation and to reveal 
phenotypes of mutant organoids. As cerebral organoids are valuable for their spatial 




the embryo; by immunohistochemistry and manual cell counting on cryosections – 
which is laborious and time consuming. Therefore, future studies should incorporate 
more high-throughput techniques to take full advantage of the potential of cerebral 
organoids. 
 
Secondly, unexpected findings in the Pax6 cKO cerebral organoids such as Cre 
mosaicism and undetectable Cre in the control (Pax6+/fl) organoids, makes it 
challenging to perform the subsequent experiment, which is to calculate the cell cycle 
kinetics of the organoids. We then took advantage of Cre mosaicism, which provides 
GFP+ and GFP- cell population within a cortical-like NE (Emx1+). GFP+ cells are 
the experimental cells as Pax6 was successfully deleted in these cells (Figure 5.7) and 
GFP- cells were used as controls.  
 
Mosaic analysis is a classic tool to examine cell autonomous functions of several 
transcription factors, including Pax6, by using Pax6 chimaeric embryos (Manuel et 
al., 2010, 2006; Quinn et al., 2007). Therefore, the cell autonomous requirement of 
Pax6 in the cerebral organoids can also be determined, which allows us to distinguish 
whether the phenotypes observed is due to the requirement of Pax6 or otherwise, 
illuminating any weaknesses in the 3D in vitro system that may require further 
improvement. Indeed, we found that Pax6 is cell non-autonomously required in 
cortical proliferation of cerebral organoids. Although this in contrast to the findings in 
vivo (Manuel et al., 2006), it could be a consequence of the in vitro artificial 
environment, which may lack some of the exogenous factors important in cortical 





However, it is important to note that although 98% of the GFP+ cells show successful 
deletion of Pax6, the GFP- cell population, which was used as control, appears to 
have a more heterogenous expression of Pax6. Therefore, calculation of the Tc might 
be overestimated. Due to time constraint, further analysis including Pax6 staining 
could not be performed; therefore, future studies should include this step and include 
GFP-/Pax6+ cells as controls. 
 
Taken together, despite the caveats outlined above, our findings are promising. 
Compared to a 2D in vitro system that lacks complexity and organisation, cerebral 
organoids are particularly suitable for addressing questions that require spatial 
information; such as cortical lamination, interkinetic nuclear migration (IKNM), 
neuronal migration, and phenotypes with positional information. Though the lack of 
developmental axes would complicate studies on cortical patterning and 
regionalisation, this could be circumvented by using specific molecular markers that 
specify caudal and rostral axes, such as COUPTF-I and Sp8, respectively (Sansom 
and Livesey, 2009). 
 
Future work should also include more detailed characterisation and optimisation of 
the mouse cerebral organoids. For example, as this study has focused on 
characterisation with several key cortical markers, other types of cells present in the 
organoids should be further discerned, such as ventral telencephalic cells, Cajal 
Retzius cells and signalling centres. The presence of these cells should also be 
systematically quantified, to determine whether the presence of these cells is random 




signaling centres, although their presence is random and infrequent compared to 
tissues with cortical characteristics (Renner et al., 2017).  
 
As discussed previously, the artificial in vitro environment might lack external 
signaling molecules important for cell proliferation in cerebral organoids. Therefore, 
further optimisation of the culture condition should also be addressed. For example, 
more signaling molecules described in the CSF can be added to the minimal medium, 
following a developmental timeline. For example, these signaling molecules should 
be added after the neural and telencephalic induction stage, which takes places on day 
one of cerebral organoid differentiation. The readout of this optimisation step could 
be through the assessment of fundamental aspect of tissue morphogenesis, such as cell 
proliferation and cell death (apoptosis). Alternatively, following aggregation of ES 
cells, cerebral organoids could also be transplanted into lateral ventricles containing 
CSF. This transplantation approach has been demonstrated to be successful in the 
survival of neurospheres, as they consist of all major types of neuronal cells such as 
neurons, microglia, astrocytes, oligodendrocytes, as well as forming mature synapse 
and axonal projections (Pothayee et al., 2018). 
 
In summary, our results show that Pax6-/- cerebral organoids are able to reproduce 
phenotypes of their matched in vivo counterparts. However, due to the complex and 
pleiotropic actions of Pax6 in cortical progenitor proliferation, the roles of Pax6 in the 
cell cycle of cortical progenitors in cerebral organoids remain unclear. It seems Pax6 
is either cell non-autonomously required, or that the expression of Pax6 in organoids 
is low, corresponding to caudo-medial region of embryonic cortex. These interesting 




addition, this study also revealed the extent of genetic manipulation tools such as Cre-
recombinase system in cerebral organoids, which was used to acutely remove Pax6 
from the system, albeit with lower efficiency than in the mouse. Overall, cerebral 
organoids are a highly prospective tool for investigating forebrain development, 
though further optimisation of the system might be necessary. For example, 
microfluidics system or air-liquid interface culture could improve diffusion of 
nutrients into the organoids, ultimately reducing cell death (Bhatia and Ingber, 2014; 
Giandomenico et al., 2019). Furthermore, limitations in analysing this system could 
also be improved by using alternative techniques such as high throughput 
quantification, such as machine learning quantification software, as well as advanced 















APPENDIX A: Result of mycoplasma test 
 
 
Sample A B B/A Result 
1 
 
1299 498 0.38 Negative 
2 
 
1106 392 0.35 Negative 
3 
 
1144 390 0.34 Negative 
4 
 
931 336 0.36 Negative 
5 
 
1209 378 0.31 Negative 
6 
 
831 265 0.32 Negative 
7 113.1 1485 894 0.60 Negative 
8 113.2 2388 1340 0.56 Negative 
9 114.1 1509 856 0.57 Negative 
10 114.3 1432 885 0.62 Negative 
11 115.7 1413 837 0.59 Negative 
12 115.9 1472 926 0.63 Negative 
13 
Positive 
C 3344 195711 58.53 Positive 
14 
Negative 


















Batch	 EDU	 DAPI	 Total	GFP	 Total	GFP-	 Total	EDU	 GFP+EDU+	 GFP-EDU+	 GFP+EDU+/GFP	 GFP-EDU+/Total	GFP-	
Batch	1	
2hr	
402	 66	 336	 118	 10	 108	 0.151515152	 0.321428571	
533	 66	 467	 119	 5	 114	 0.075757576	 0.244111349	
632	 178	 454	 134	 45	 89	 0.252808989	 0.196035242	
		 		 		 		 		 		 		 		 		
4hr	
538	 89	 449	 113	 17	 96	 0.191011236	 0.213808463	
454	 175	 279	 110	 38	 72	 0.217142857	 0.258064516	
239	 63	 176	 53	 7	 46	 0.111111111	 0.261363636	
		 		 		 		 		 		 		 		 		
6hr	
455	 105	 350	 119	 23	 96	 0.219047619	 0.274285714	
473	 121	 352	 131	 33	 98	 0.272727273	 0.278409091	
239	 72	 167	 65	 12	 53	 0.166666667	 0.317365269	
		 		 		 		 		 		 		 		 		
8h	
480	 145	 335	 143	 44	 99	 0.303448276	 0.295522388	
379	 122	 257	 112	 21	 91	 0.172131148	 0.354085603	
482	 110	 372	 168	 29	 139	 0.263636364	 0.373655914	
		 		 		 		 		 		 		 		 		
10h	
430	 92	 338	 172	 35	 137	 0.380434783	 0.405325444	
465	 112	 353	 239	 46	 193	 0.410714286	 0.54674221	






Batch	 EDU	 DAPI	 Total	GFP	 Total	GFP-	 Total	EDU	 GFP+EDU+	 GFP-EDU+	 GFP+EDU+/GFP	 GFP-EDU+/Total	GFP-	
Batch	2	
2hr	
223	 48	 175	 62	 9	 53	 0.1875	 0.302857143	
318	 68	 250	 71	 8	 63	 0.117647059	 0.252	
362	 76	 286	 77	 13	 64	 0.171052632	 0.223776224	
		 		 		 		 		 		 		 		 		
4hr	
438	 153	 285	 110	 30	 80	 0.196078431	 0.280701754	
307	 67	 240	 71	 10	 61	 0.149253731	 0.254166667	
410	 78	 332	 108	 12	 96	 0.153846154	 0.289156627	
		 		 		 		 		 		 		 		 		
6hr	
393	 168	 225	 127	 48	 79	 0.285714286	 0.351111111	
303	 118	 185	 94	 31	 63	 0.262711864	 0.340540541	
359	 146	 213	 137	 69	 68	 0.47260274	 0.319248826	
		 		 		 		 		 		 		 		 		
8hr	
340	 72	 268	 112	 28	 84	 0.388888889	 0.313432836	
312	 73	 239	 114	 13	 101	 0.178082192	 0.422594142	
270	 32	 238	 100	 3	 97	 0.09375	 0.407563025	
		 		 		 		 		 		 		 		 		
10hr	
401	 52	 349	 149	 10	 139	 0.192307692	 0.398280802	
291	 24	 267	 137	 8	 129	 0.333333333	 0.483146067	






Batch	 EDU	 DAPI	 Total	GFP	 Total	GFP-	 Total	EDU	 GFP+EDU+	 GFP-EDU+	 GFP+EDU+/GFP	 GFP-EDU+/Total	GFP-	
Batch	3	
2hr	
350	 19	 331	 109	 1	 108	 0.052631579	 0.326283988	
439	 13	 426	 117	 2	 115	 0.153846154	 0.269953052	
252	 8	 244	 85	 2	 83	 0.25	 0.340163934	
		 		 		 		 		 		 		 		 		
4hr	
336	 7	 329	 89	 1	 88	 0.142857143	 0.267477204	
265	 19	 246	 64	 4	 60	 0.210526316	 0.243902439	
284	 42	 242	 79	 12	 67	 0.285714286	 0.276859504	
		 		 		 		 		 		 		 		 		
6hr	
306	 61	 245	 102	 17	 85	 0.278688525	 0.346938776	
253	 21	 232	 87	 3	 84	 0.142857143	 0.362068966	
534	 49	 485	 131	 16	 115	 0.326530612	 0.237113402	
		 		 		 		 		 		 		 		 		
8hr	
382	 56	 326	 96	 8	 88	 0.142857143	 0.26993865	
435	 18	 417	 141	 0	 141	 0	 0.338129496	
355	 61	 294	 145	 19	 126	 0.31147541	 0.428571429	
		 		 		 		 		 		 		 		 		
10hr	
249	 48	 201	 85	 13	 72	 0.270833333	 0.358208955	
361	 81	 280	 175	 30	 145	 0.37037037	 0.517857143	









Batch	 EDU	 DAPI	 Total	GFP	 Total	GFP-	 Total	EDU	 GFP+EDU+	 GFP-EDU+	 GFP+EDU+/GFP	 GFP-EDU+/GFP-	
Batch	1	
2hr	
335	 82	 253	 146	 30	 116	 0.365853659	 0.458498024	
460	 80	 380	 121	 11	 110	 0.1375	 0.289473684	
353	 33	 320	 79	 9	 70	 0.272727273	 0.21875	
		 		 		 		 		 		 		 		 		
4hr	
297	 21	 276	 62	 4	 58	 0.19047619	 0.210144928	
271	 54	 217	 80	 15	 65	 0.277777778	 0.299539171	
315	 50	 265	 111	 11	 100	 0.22	 0.377358491	
		 		 		 		 		 		 		 		 		
6h	
325	 49	 276	 104	 9	 95	 0.183673469	 0.344202899	
610	 159	 451	 227	 55	 172	 0.34591195	 0.381374723	
464	 72	 392	 130	 24	 106	 0.333333333	 0.270408163	
		 		 		 		 		 		 		 		 		
8h	
288	 90	 198	 155	 30	 125	 0.333333333	 0.631313131	
451	 65	 386	 182	 18	 164	 0.276923077	 0.424870466	
300	 94	 206	 111	 36	 75	 0.382978723	 0.36407767	
		 		 		 		 		 		 		 		 		
10h	
326	 99	 227	 114	 28	 86	 0.282828283	 0.378854626	
421	 89	 332	 192	 24	 168	 0.269662921	 0.506024096	






Batch	 EDU	 DAPI	 Total	GFP	 Total	GFP-	 Total	EDU	 GFP+EDU+	 GFP-EDU+	 GFP+EDU+/GFP	 GFP-EDU+/GFP-	
Batch	2	
2hr	
323	 33	 290	 91	 5	 86	 0.151515152	 0.296551724	
337	 48	 289	 97	 8	 89	 0.166666667	 0.307958478	
384	 79	 305	 75	 15	 60	 0.189873418	 0.196721311	
		 		 		 		 		 		 		 		 		
4hr	
344	 42	 302	 70	 7	 63	 0.166666667	 0.208609272	
351	 56	 295	 84	 15	 69	 0.267857143	 0.233898305	
348	 38	 310	 75	 8	 67	 0.210526316	 0.216129032	
		 		 		 		 		 		 		 		 		
6hr	
386	 158	 228	 135	 46	 89	 0.291139241	 0.390350877	
423	 49	 374	 140	 22	 118	 0.448979592	 0.315508021	
343	 78	 265	 117	 23	 94	 0.294871795	 0.354716981	
		 		 		 		 		 		 		 		 		
8hr	
324	 117	 207	 166	 45	 121	 0.384615385	 0.584541063	
478	 48	 430	 163	 20	 143	 0.416666667	 0.33255814	
430	 92	 338	 96	 16	 80	 0.173913043	 0.236686391	
		 		 		 		 		 		 		 		 		
10hr	
346	 115	 231	 132	 44	 88	 0.382608696	 0.380952381	
375	 46	 329	 121	 18	 103	 0.391304348	 0.313069909	





Batch	 EDU	 DAPI	 Total	GFP	 Total	GFP-	 Total	EDU	 GFP+EDU+	 GFP-EDU+	 GFP+EDU+/GFP	 GFP-EDU+/GFP-	
Batch	3	
2hr	
393	 12	 381	 118	 2	 116	 0.166666667	 0.304461942	
443	 35	 408	 69	 3	 66	 0.085714286	 0.161764706	
247	 6	 241	 45	 4	 41	 0.666666667	 0.170124481	
		 		 		 		 		 		 		 		 		
4hr	
120	 18	 102	 33	 3	 30	 0.166666667	 0.294117647	
241	 28	 213	 77	 11	 66	 0.392857143	 0.309859155	
561	 8	 553	 112	 0	 112	 0	 0.202531646	
		 		 		 		 		 		 		 		 		
6hr	
445	 29	 416	 109	 5	 104	 0.172413793	 0.25	
279	 27	 252	 88	 8	 80	 0.296296296	 0.317460317	
286	 30	 256	 69	 7	 62	 0.233333333	 0.2421875	
		 		 		 		 		 		 		 		 		
8hr	
438	 69	 369	 186	 25	 161	 0.362318841	 0.436314363	
312	 103	 209	 138	 35	 103	 0.339805825	 0.492822967	
284	 12	 272	 73	 4	 69	 0.333333333	 0.253676471	
		 		 		 		 		 		 		 		 		
10hr	
383	 122	 261	 144	 31	 113	 0.254098361	 0.432950192	
243	 27	 216	 103	 9	 94	 0.333333333	 0.435185185	
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